XTI Aerospace (XTIA) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 14, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-36404
Entity Registrant Name	XTI AEROSPACE, INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	88-0434915
Entity Address, Address Line One	8123 InterPort Blvd
Entity Address, Address Line Two	Suite C
Entity Address, City or Town	Englewood
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80112
City Area Code	800
Local Phone Number	680-7412
Title of 12(b) Security	Common Stock, par value $0.001
Trading Symbol	XTIA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		151,589,927
Entity Central Index Key	0001529113
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 511	$ 5
Accounts receivable, net of allowance for credit losses of $33 and $0 as of September 30, 2024 and December 31, 2023, respectively	610	0
Other receivables	552	101
Inventory	2,730	0
Note receivable available for sale, at fair value	3,601	0
Warrant asset	424	0
Prepaid expenses and other current assets	1,704	125
Total Current Assets	10,132	231
Property and equipment, net	235	12
Operating lease right-of-use asset, net	522	0
Intangible assets, net	4,778	266
Goodwill	12,738	0
Other assets	878	0
Total Assets	29,283	509
Current Liabilities
Accrued expenses and other current liabilities	8,659	1,127
Accrued interest	940	560
Customer deposits	1,350	1,350
Warrant liability	0	497
Operating lease obligation, current	217	0
Deferred revenue	526	0
Short-term debt	2,620	6,690
Total Current Liabilities	22,037	13,259
Long Term Liabilities
Long-term debt	65	18,546
Operating lease obligation, noncurrent	316	0
Other liabilities, noncurrent	0	333
Total Liabilities	22,418	32,138
Commitments and Contingencies (Note 18)
Stockholders’ Equity (Deficit)
Common Stock - $0.001 par value; 500,000,000 shares authorized; 38,008,995 and 3,197,771 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.	38	3
Additional paid-in capital	79,332	26,327
Accumulated other comprehensive loss	524	0
Accumulated deficit	(79,706)	(57,959)
Total Stockholders’ Equity (Deficit)	6,865	(31,629)
Total Liabilities and Stockholders’ Equity (Deficit)	29,283	509
Related Party
Current Liabilities
Payable	100	540
Nonrelated Party
Current Liabilities
Payable	7,625	2,495
Series 4 Convertible Preferred Stock
Stockholders’ Equity (Deficit)
Preferred stock	0	0
Series 5 Convertible Preferred Stock
Stockholders’ Equity (Deficit)
Preferred stock	0	0
Series 9 Preferred Stock
Stockholders’ Equity (Deficit)
Preferred stock	$ 6,677	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Accounts receivable allowance, net	$ 33,000	$ 0
Preferred stock, par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Common stock, par value (in usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	38,008,995	3,197,771
Common stock, shares outstanding (in shares)	38,008,995	3,197,771
Series 4 Convertible Preferred Stock
Preferred stock, shares authorized (in shares)	10,415	10,415
Preferred stock, shares issued (in shares)	1	1
Preferred stock, shares outstanding (in shares)	1	1
Series 5 Convertible Preferred Stock
Preferred stock, shares authorized (in shares)	12,000	12,000
Preferred stock, shares issued (in shares)	126	126
Preferred stock, shares outstanding (in shares)	126	126
Series 9 Preferred Stock
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	11,302	0
Preferred stock, shares outstanding (in shares)	6,677	0
Preferred stock at redemption, liquidation preference	$ 7,506,833	$ 7,506,833

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 918	$ 0	$ 2,169	$ 0
Cost of Revenues	398	0	846	0
Gross Profit	520	0	1,323	0
Operating Expenses
Research and development	1,228	472	2,840	1,299
Sales and marketing	1,019	198	2,160	486
General and administrative	2,293	988	16,422	4,469
Merger-related transaction costs	0	713	6,490	1,428
Amortization of intangible assets	196	7	431	20
Total Operating Expenses	4,736	2,378	28,343	7,702
Loss from Operations	(4,216)	(2,378)	(27,020)	(7,702)
Other Income (Expense)
Interest expense, net	(222)	(303)	(553)	(806)
Amortization of deferred loan costs	0	(22)	(17)	(66)
Inducement loss on debt conversions	0	0	(6,732)	0
Change in fair value of convertible notes	0	0	12,882	0
Change in fair value of JV obligation	0	0	0	(197)
Change in fair value of warrant liability	0	0	(281)	(126)
Other income/(expense), net	3	0	(10)	0
Total Other Income (Expense)	(219)	(325)	5,289	(1,195)
Net Loss, before tax	(4,435)	(2,703)	(21,731)	(8,897)
Income tax provision	0	0	(16)	0
Net Loss	(4,435)	(2,703)	(21,747)	(8,897)
Less: Preferred stock return and dividend	(185)	0	(496)	0
Less: Deemed dividend	(54)	0	(514)	0
Net Loss Attributable to Common Stockholders, basic	(4,674)	(2,703)	(22,757)	(8,897)
Net Loss Attributable to Common Stockholders, diluted	$ (4,674)	$ (2,703)	$ (22,757)	$ (8,897)
Net Loss Per Share
Net Loss Per Share - Basic (in usd per share)	$ (0.13)	$ (0.66)	$ (1.23)	$ (2.26)
Net Loss Per Share - Diluted (in usd per share)	$ (0.13)	$ (0.66)	$ (1.23)	$ (2.26)
Weighted Average Number of Shares Outstanding
Basic (in shares)	34,986,105	4,116,700	18,439,744	3,931,075
Diluted (in shares)	34,986,105	4,116,700	18,439,744	3,931,075

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net Loss	$ (4,435)	$ (2,703)	$ (21,747)	$ (8,897)
Change in fair value of convertible note receivable	0	0	59	0
Unrealized foreign exchange loss from cumulative translation adjustments	663	0	465	0
Comprehensive Loss	$ (3,772)	$ (2,703)	$ (21,223)	$ (8,897)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	December 2023 Warrant Exchange	Public Offering	Nonrelated Party	Common Stock	Common Stock Public Offering	Common Stock Nonrelated Party	Additional Paid-In Capital	Additional Paid-In Capital December 2023 Warrant Exchange	Additional Paid-In Capital Public Offering	Additional Paid-In Capital Nonrelated Party	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Series 9 Preferred Stock	Series 9 Preferred Stock Series 9 Preferred Stock at Redemption Value	Series 9 Preferred Stock Common Stock	Series 9 Preferred Stock Additional Paid-In Capital
Balance, beginning (in shares) at Dec. 31, 2022															0
Balance, beginning (in shares) at Dec. 31, 2022					3,181,578
Balance, beginning at Dec. 31, 2022	$ (14,982)				$ 3			$ 17,908				$ 0	$ (32,893)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,565)												(1,565)
Stock-based compensation	141							141
Issuance of warrants with convertible note	39							39
Balance, ending (in shares) at Mar. 31, 2023															0
Balance, ending at Mar. 31, 2023	(16,367)				$ 3			18,088				0	(34,458)		$ 0
Balance, ending (in shares) at Mar. 31, 2023					3,181,578
Balance, beginning (in shares) at Dec. 31, 2022															0
Balance, beginning (in shares) at Dec. 31, 2022					3,181,578
Balance, beginning at Dec. 31, 2022	(14,982)				$ 3			17,908				0	(32,893)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,897)
Change in fair value of convertible note receivable	0
Balance, ending (in shares) at Sep. 30, 2023															0
Balance, ending at Sep. 30, 2023	(14,339)				$ 3			27,448				0	(41,790)		$ 0
Balance, ending (in shares) at Sep. 30, 2023					3,197,573
Balance, beginning (in shares) at Mar. 31, 2023															0
Balance, beginning (in shares) at Mar. 31, 2023					3,181,578
Balance, beginning at Mar. 31, 2023	(16,367)				$ 3			18,088				0	(34,458)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (4,629)												(4,629)
Stock issued during period, shares, new issues (in shares)	12,853
Stock issued during period, value, new issues	$ 180							180
Stock-based compensation	2,461							2,461
Issuance of warrants with convertible note	928							928
JV obligation reclassified to equity	5,583
Balance, ending (in shares) at Jun. 30, 2023															0
Balance, ending at Jun. 30, 2023	(11,844)				$ 3			27,240				0	(39,087)		$ 0
Balance, ending (in shares) at Jun. 30, 2023					3,194,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (2,703)												(2,703)
Stock issued during period, shares, new issues (in shares)	3,142
Stock issued during period, value, new issues	$ 44							44
Stock-based compensation	164							164
Change in fair value of convertible note receivable	0
Balance, ending (in shares) at Sep. 30, 2023															0
Balance, ending at Sep. 30, 2023	$ (14,339)				$ 3			27,448				0	(41,790)		$ 0
Balance, ending (in shares) at Sep. 30, 2023					3,197,573
Balance, beginning (in shares) at Dec. 31, 2023														0	0
Balance, beginning (in shares) at Dec. 31, 2023	3,197,771				3,197,771
Balance, beginning at Dec. 31, 2023	$ (31,629)				$ 3			26,327				0	(57,959)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for conversion of convertible securities (in shares)							2,887,788
Stock issued during period, value, conversion of convertible securities				$ 9,614			$ 3				$ 9,611
Inducement loss on debt conversions	6,732							6,732
Common stock issued to Xeriant, Inc. (in shares)					298,395
Common stock issued for exercise of warrants (in shares)					482,015
Common shares issued for cashless exercise of warrants and options	0				$ 1			(1)
Common and preferred shares issued via merger (in shares)					2,075,743										11,302
Common and preferred shares issued via merger	25,605				$ 2			14,301							$ 11,302
Capital contribution - forgiveness of related party payable	380							380
Stock based compensation (in shares)					977,699
Stock-based compensation	5,792				$ 1			5,791
Cumulative translation adjustment	(166)											(166)
Series 9 preferred stock dividend accrued	(61)							(61)
Net loss	(2,602)												(2,602)
Balance, ending (in shares) at Mar. 31, 2024															11,302
Balance, ending at Mar. 31, 2024	$ 13,665				$ 10			63,080				(166)	(60,561)		$ 11,302
Balance, ending (in shares) at Mar. 31, 2024					9,919,411
Balance, beginning (in shares) at Dec. 31, 2023														0	0
Balance, beginning (in shares) at Dec. 31, 2023	3,197,771				3,197,771
Balance, beginning at Dec. 31, 2023	$ (31,629)				$ 3			26,327				0	(57,959)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(21,747)
Change in fair value of convertible note receivable	59
Balance, ending (in shares) at Sep. 30, 2024														6,677	6,677
Balance, ending at Sep. 30, 2024	$ 6,865				$ 38			79,332				524	(79,706)		$ 6,677
Balance, ending (in shares) at Sep. 30, 2024	38,008,995				38,008,995
Balance, beginning (in shares) at Mar. 31, 2024															11,302
Balance, beginning (in shares) at Mar. 31, 2024					9,919,411
Balance, beginning at Mar. 31, 2024	$ 13,665				$ 10			63,080				(166)	(60,561)		$ 11,302
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for conversion of convertible securities (in shares)															(3,550)	2,999,187
Stock issued during period, value, conversion of convertible securities														$ 177	$ (3,550)	$ 3	$ 3,724
Stock-based compensation	(59)							(59)
Cumulative translation adjustment	(32)											(32)
Series 9 preferred stock dividend accrued	(250)							(250)
Net loss	(14,710)												(14,710)
Deemed dividend related to Series 9 preferred stock exchange														$ (177)			(177)
Common shares issued in exchange of warrants (in shares)					1,492,415
Common shares issued in exchange of warrants	1,981				$ 2			1,979
Deemed dividend related to December 2023 warrant exchange		$ (283)							$ (283)
Common shares issued in exchange of warrants (in shares)					20,528
Common shares issued for exercise of warrants	2							2
Stock issued during period, shares, new issues (in shares)						9,300,203
Stock issued during period, value, new issues			$ 8,675			$ 9				$ 8,666
Common shares issued as settlement of accrued compensation (in shares)					2,680,459
Common shares issued as settlement of accrued compensation	1,192				$ 3			1,189
Common shares issued as prepayment for marketing services (in shares)					429,483
Common shares issued as prepayment for services	335							335
Change in fair value of convertible note receivable	59											59
Balance, ending (in shares) at Jun. 30, 2024															7,752
Balance, ending at Jun. 30, 2024	10,575				$ 27			78,206				(139)	(75,271)		$ 7,752
Balance, ending (in shares) at Jun. 30, 2024					26,841,686
Balance, beginning (in shares) at Mar. 31, 2024															11,302
Balance, beginning (in shares) at Mar. 31, 2024					9,919,411
Balance, beginning at Mar. 31, 2024	13,665				$ 10			63,080				(166)	(60,561)		$ 11,302
Balance, ending (in shares) at Sep. 30, 2024														6,677	6,677
Balance, ending at Sep. 30, 2024	$ 6,865				$ 38			79,332				524	(79,706)		$ 6,677
Balance, ending (in shares) at Sep. 30, 2024	38,008,995				38,008,995
Balance, beginning (in shares) at Jun. 30, 2024															7,752
Balance, beginning (in shares) at Jun. 30, 2024					26,841,686
Balance, beginning at Jun. 30, 2024	$ 10,575				$ 27			78,206				(139)	(75,271)		$ 7,752
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for conversion of convertible securities (in shares)															(1,075)	4,196,813
Stock issued during period, value, conversion of convertible securities														$ 54	$ (1,075)	$ 4	1,125
Stock based compensation (in shares)					1,004,886
Stock-based compensation	(1,889)				$ 1			(1,890)
Cumulative translation adjustment	663											663
Series 9 preferred stock dividend accrued	(185)							(185)
Net loss	(4,435)												(4,435)
Deemed dividend related to Series 9 preferred stock exchange														$ (54)			$ (54)
Stock issued during period, shares, new issues (in shares)						3,190,727
Stock issued during period, value, new issues			$ 1,035			$ 3				$ 1,032
Common shares issued as settlement of accrued compensation (in shares)					2,774,883
Common shares issued as settlement of accrued compensation	1,101				$ 3			1,098
Change in fair value of convertible note receivable	0
Balance, ending (in shares) at Sep. 30, 2024														6,677	6,677
Balance, ending at Sep. 30, 2024	$ 6,865				$ 38			$ 79,332				$ 524	$ (79,706)		$ 6,677
Balance, ending (in shares) at Sep. 30, 2024	38,008,995				38,008,995

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows Used in Operating Activities
Net loss	$ (21,747)	$ (8,897)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	81	8
Amortization of intangible assets	431	20
Amortization of right-of-use asset	177	0
Non-cash interest expense, net	267	456
Stock-based compensation	3,844	2,766
Change in fair value of JV obligation	0	197
Change in fair value of convertible notes payable	(12,882)	0
Inducement loss on debt conversions	6,732	0
Change in fair value of warrant liability	281	126
Change in fair value of warrant asset	24	0
Unrealized gain on foreign currency transactions	(123)	0
Other	34	0
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(72)	127
Inventory	271	0
Prepaid expenses and other current assets	247	28
Other assets	32	0
Accounts payable	2,514	1,160
Related party payables	0	64
Accrued expenses and other current liabilities	5,708	561
Accrued interest	154	398
Deferred revenue	(115)	0
Operating lease obligation	(163)	0
Net Cash Used in Operating Activities	(14,305)	(2,986)
Cash Flows Provided by Investing Activities
Purchase of property and equipment	(54)	(3)
Cash received in purchase of Inpixon	2,968	0
Purchase of intangible asset	(39)	0
Net Cash Provided by Investing Activities	2,875	(3)
Cash Provided by Financing Activities
Proceeds from sale of common stock and exercise of warrants	2	224
Net proceeds from ATM stock offering	9,582	0
Net proceeds from promissory notes	2,000	2,150
Net proceeds from loan from Inpixon (prior to merger)	1,012	0
Net proceeds from convertible notes	0	750
Repayments of promissory notes	(668)	(14)
Net Cash Provided by Financing Activities	11,928	3,110
Effect of Foreign Exchange Rate on Changes on Cash	8	0
Net Increase (Decrease) in Cash and Cash Equivalents	506	121
Cash and Cash Equivalents - Beginning of period	5	115
Cash and Cash Equivalents - End of period	511	236
Cash paid for:
Interest	54	1
Income Taxes	16	0
Non-cash investing and financing activities
Common shares issued for conversion of debt and accrued interest	9,614	0
Common shares issued in exchange of warrants	1,698	0
Deemed dividend related to December 2023 warrant exchange	283	0
Common shares issued as settlement of accrued compensation	2,293	0
Common shares issued as prepayment for services	335	0
Issuance of common stock for merger consideration, net of cash received	22,637	0
Right of use asset obtained in exchange for lease liability	394	0
Capital contribution - forgiveness of related party payable	380	0
Series 9 preferred stock dividend accrued	496	0
Deemed dividend related to Series 9 preferred stock exchange	231	0
ATM proceeds withheld as payment towards accounts payable	128	0
Warrants issued with convertible notes	0	967
Warrants issued with common stock	0	121
Reclassification of JV obligation to equity	0	5,583
Series 9 Preferred Stock
Non-cash investing and financing activities
Common shares issued in exchange of Series 9 preferred stock	$ 4,625	$ 0

Organization and Nature of Busi

Organization and Nature of Business	9 Months Ended
	Sep. 30, 2024
Organization and Nature of Business and Going Concern [Abstract]
Organization and Nature of Business	Organization and Nature of Business On March 12, 2024 (the "Closing Date"), XTI Aerospace, Inc., the "Company", formerly known as Inpixon (“Legacy Inpixon”), Superfly Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Legacy Inpixon (“Merger Sub”), and XTI Aircraft Company, a Delaware corporation (“Legacy XTI”), completed their previously announced merger transaction pursuant to that certain Agreement and Plan of Merger, dated as of July 24, 2023 and amended on December 30, 2023 and March 12, 2024 (the “XTI Merger Agreement”), pursuant to which Legacy XTI merged in a reverse triangular merger with Merger Sub with Legacy XTI surviving the merger as a wholly-owned subsidiary of the Company (the “XTI Merger”). In connection with the closing of the XTI Merger, our corporate name changed from Inpixon to “XTI Aerospace, Inc.” and the combined company opened for trading on the Nasdaq Capital Market on March 13, 2024 under the new ticker symbol “XTIA.” The Company determined the XTI Merger should be accounted for as a reverse acquisition with Legacy XTI being considered the accounting acquirer. Therefore, the condensed consolidated financial statements included in this report represent a continuation of the financial statements of Legacy XTI and the results of operations of the accounting acquired entity, Legacy Inpixon, are included in the condensed consolidated financial statements as of the Closing Date and through the September 30, 2024 reporting date. Following the closing of the XTI Merger, the Company is primarily an aircraft development company. The Company also provides real-time location systems (“RTLS”) for the industrial sector, which was Legacy Inpixon's focus prior to the closing of the XTI Merger. Headquartered in Englewood, Colorado, the Company is developing a vertical takeoff and landing ("VTOL") aircraft that is designed to take off and land like a helicopter and cruise like a fixed-wing business aircraft. Since 2013, the Company has been engaged primarily in developing the design and engineering concepts for the TriFan 600, building and testing a two-thirds scale unmanned version of the TriFan 600, generating pre-orders for the TriFan 600, and seeking funds from investors to enable the Company to build full-scale piloted prototypes of the TriFan 600, and to eventually engage in commercial production and sale of TriFan 600.

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of PresentationThe accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Interim results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results for the full year ending December 31, 2024. These interim unaudited condensed consolidated financial statements should be read in conjunction with Legacy Inpixon's audited financial statements and notes for the years ended December 31, 2023 and 2022 included in the annual report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 16, 2024. These interim unaudited condensed consolidated financial statements should also be read in conjunction with Legacy XTI's audited financial statements and notes for the years ended December 31, 2023 and 2022 included in the Form 8-K/A filed with the SEC on May 28, 2024.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The Company's complete accounting policies are described in Note 2 to Legacy Inpixon's audited consolidated financial statements and notes for the year ended December 31, 2023, except for Legacy XTI's accounting policies which have been incorporated into this Note 3. Liquidity and Going Concern As of September 30, 2024, the Company has a working capital deficit of approximately $11.9 million, and cash of approximately $0.5 million. For the nine months ended September 30, 2024, the Company had a net loss of approximately $21.7 million. During the nine months ended September 30, 2024, the Company used approximately $14.3 million of cash for operating activities. There can be no assurances that the Company will ever earn revenues sufficient to support its operations, or that it will ever be profitable. In order to continue its operations, the Company has supplemented the revenues it earned with proceeds from the sale of its equity and debt securities and proceeds from loans and bank credit lines. The Company's recurring losses and utilization of cash in its operations are indicators of going concern. The Company’s condensed consolidated financial statements as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023 have been prepared under the assumption that the Company will continue as a going concern for the next twelve months from the date the financial statements are issued. Management’s plans and assessment of the probability that such plans will mitigate and alleviate any substantial doubt about the Company’s ability to continue as a going concern is dependent upon the Company's ability to obtain additional equity or debt financing, and attain further operating efficiency, which is uncertain, which together represent the principal conditions that raise substantial doubt about our ability to continue as a going concern. The Company’s condensed consolidated financial statements as of and for the three and nine months ended September 30, 2024 and 2023 do not include any adjustments that might result from the outcome of this uncertainty. Consolidations The consolidated financial statements have been prepared using the accounting records of Legacy XTI and as of March 12, 2024 and forward (the effective date of the XTI Merger) the accounting records of XTI Aerospace, Inc. (formerly known as Inpixon), Inpixon GmbH (formerly known as Nanotron Technologies GmbH), Inpixon Holding UK Limited, and Intranav GmbH. All material inter-company balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of: • the valuation of stock-based compensation; • the valuation of the Company’s common stock issued and assets acquired in transactions, including acquisitions; • the valuation of equity securities; • the valuation of notes receivable; • the valuation of warrant liabilities and assets; • the valuation of convertible notes, at fair value; • the valuation of loan conversion derivatives; and • the valuation allowance for deferred tax assets. Cash and Cash Equivalents Cash consists primarily of demand deposit bank accounts, which, from time to time, may exceed federally insured limits. The Company considers all highly liquid investments with an original maturity from date of purchase of three months or less, or that are readily convertible into known amounts of cash, to be cash equivalents. Credit Risk and Concentrations Financial instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk. The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk of its customers, establishes an allowance for credit losses. The customers who account for 10% or more of the Company's revenue for the three and nine months ended September 30, 2024 or 10% or more of the Company's outstanding receivable balance as of September 30, 2024 are presented as follows: Percentage of revenues Percentage of accounts receivable Customer For the Three Months Ended September 30, 2024 For the Nine Months Ended September 30, 2024 As of September 30, 2024 A 25% 23% ** B ** 17% ** C 25% 16% 29% D 13% 12% 10% E ** ** 10% F ** ** 24% **Represents less than 10% of the total for the respective period The Company did not have revenue for the three and nine months ended September 30, 2023. The Company did not have outstanding trade receivables as of September 30, 2023. The vendors who account for 10% or more of the Company's purchases or 10% or more of the Company's outstanding payable balance are presented as follows for the periods indicated: Percentage of purchases Percentage of accounts payable Three Months Ended September 30, Nine Months Ended September 30, As of September 30, Vendor 2024 2023 2024 2023 2024 2023 A ** 45% ** 42% 21% 61% B ** ** ** 11% ** ** C ** ** ** ** ** 23% **Represents less than 10% of the total for the respective period Business Combinations The Company accounts for business combinations under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805, “Business Combinations” using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Acquired In-Process Research and Development (“IPR&D”) In accordance with authoritative guidance, the Company recognizes IPR&D at fair value as of the acquisition date, and subsequently accounts for it as an indefinite-lived intangible asset until completion or abandonment of the associated research and development efforts. Once an IPR&D project has been completed, the useful life of the IPR&D asset is determined and amortized accordingly. If the IPR&D asset is abandoned, the remaining carrying value is written off. During fiscal year 2024, the Company acquired IPR&D through the XTI Merger. Intangible Assets and Goodwill Intangible assets primarily consist of developed technology, patents, customer relationships, and trade names/trademarks. They are amortized ratably over a range of 5 to 15 years, which approximates customer attrition rate and technology obsolescence. The Company tests goodwill for potential impairment at least annually as of October 1, or more frequently if events or changes in circumstances indicate that the asset may be impaired . Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying amount and the Company recognizes an impairment charge, if any, for the amount by which the carrying amount exceeds the reporting unit’s fair value. Based on its assessments, the Company does not believe it has a goodwill impairment during the nine months ended September 30, 2024 and 2023. Impairment of Long-Lived Assets The Company reviews its long-lived assets, inclusive of its right-of-use assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated from the use of the asset and its eventual disposition. If the carrying amount of an asset group exceeds its estimated future undiscounted cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset group exceeds its fair value. For the nine months ended September 30, 2024 and 2023, the Company determined none of its long-lived assets were impaired. Revenue Recognition In accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer. Hardware and Software Revenue Recognition For sales of hardware and software products, the Company’s performance obligation is satisfied at a point in time when they are shipped to the customer, at which control is deemed transferred to the customer, and has title of the product and holds the risks and rewards of ownership. The Company leverages drop-ship arrangements with many of its vendors and suppliers to deliver products to customers without having to physically hold the inventory at its warehouse. In such arrangements, the Company negotiates the sale price with the customer, pays the supplier directly for the product shipped, bears credit risk of collecting payment from its customers and is ultimately responsible for the acceptability of the product and ensuring that such product meets the standards and requirements of the customer. Accordingly, the Company concluded it is the principal in the transaction with the customer and records revenue on a gross basis. The Company receives fixed consideration for sales of hardware and software products. The Company’s customers generally pay within 30 to 60 days from the receipt of a customer approved invoice. The Company has elected the practical expedient to expense the costs of obtaining a contract when they are incurred because the amortization period of the asset that otherwise would have been recognized is less than a year. Software As A Service Revenue Recognition With respect to sales of the Company’s maintenance, consulting and other service agreements, customers pay fixed monthly fees in exchange for the Company’s service. The Company’s performance obligation is satisfied over time as the digital advertising and electronic services are provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous access to its service. Professional Services Revenue Recognition The Company’s professional services include milestone, fixed fee and time and materials contracts. Professional services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract can be estimated reliably, contract revenue is recognized in the consolidated statement of operations in proportion to the stage of completion of the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract, are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract. Professional services are also contracted on the fixed fee and time and materials basis. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company’s time and materials contracts are paid weekly or monthly based on hours worked. Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date. For fixed fee contracts including maintenance service provided by in house personnel, the Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous service. Because the Company’s contracts have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the nine months ended September 30, 2024 and 2023, the Company did not incur any such losses. These amounts are based on known and estimated factors. License Revenue Recognition The Company enters into contracts with its customers whereby it grants a non-exclusive on-premise license for the use of its proprietary software. The contracts provide for a stated term with a one year or multiple year renewal option. The contracts may also provide for yearly on-going maintenance services for a specified price, which includes maintenance services, designated support, and enhancements, upgrades and improvements to the software (the “Maintenance Services”), depending on the contract. Licenses for on-premises software provide the customer with a right to use the software as it exists when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over which the customer benefits from the software. The timing of the Company's revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement entered into represents a good or service. Software that relies on an entity’s IP and is delivered only through a hosting arrangement, where the customer cannot take possession of the software, is a service. A software arrangement that is provided through an access code or key represents the transfer of a good. Licenses for on-premises software represents a good and provide the customer with a right to use the software as it exists when made available to the customer. Customers may purchase perpetual licenses or subscribe to licenses, which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software. Revenue from distinct on-premises licenses is recognized upfront at the point in time when the software is made available to the customer. Renewals or extensions of licenses are evaluated as distinct licenses (i.e., a distinct good or service), and revenue attributed to the distinct good or service cannot be recognized until (1) the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. Therefore, the Company recognizes revenue resulting from renewal of licensed software at a point in time, specifically, at the beginning of the license renewal period. The Company recognizes revenue related to Maintenance Services evenly over the service period using a time-based measure because the Company is providing continuous service and the customer simultaneously receives and consumes the benefits provided by the Company’s performance as the services are performed. Contract Balances The timing of the Company’s revenue recognition may differ from the timing of payment by its customers. The Company records a receivable when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied, principally within one year. Customer Deposits The Company periodically enters into aircraft reservation agreements that include a deposit placed by a potential customer. The deposits serve to prioritize orders when the aircraft becomes available for delivery. Customers making deposits are not obligated to purchase aircraft until they execute a definitive purchase agreement. Customers may request return of their deposit any time up until the execution of a purchase agreement. The Company records such advance deposits as a liability and defers the related revenue recognition until delivery of an aircraft occurs, if any. Stock-Based Compensation The Company’s stock-based compensation relates to stock options granted to employees and non-employees. The Company recognizes the cost of share-based awards granted to employees and non-employees based on the estimated grant-date fair value of the awards. Forfeitures are accounted for as they occur, which may result in negative expense when forfeitures exceed the expense recorded within the period. The Company recognizes expense on a straight-line basis over the requisite service period of the award, which is generally equal to the vesting period of the award. The Company estimates the grant-date fair value of the stock option awards with service only vesting conditions using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model utilizes inputs and assumptions which involve inherent uncertainties and generally require significant judgment. As a result, if factors or expected outcomes change and significantly different assumptions or estimates are used, the Company’s stock-based compensation could be materially different. Significant inputs and assumptions include: Fair value of Common Stock – As there was no public market for Legacy XTI’s common stock prior to the XTI Merger, the fair value of the shares of common stock underlying the stock-based awards on the grant-date has historically been determined by Legacy XTI’s Board of Directors with assistance of third-party valuation specialists. Legacy XTI's Board of Directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair market value, which included important developments in Legacy XTI’s operations, actual operating results, financial performance, external market conditions, equity market conditions of comparable public companies, and the lack of marketability of Legacy XTI’s common stock. Expected Term – The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term). Expected Volatility – Because Legacy XTI was privately held prior to the XTI Merger and did not have an active trading market for its common stock, the expected volatility was estimated based on the average volatility for publicly traded companies that the Company considers to be comparable, over a period equal to the expected term of the stock option grants. Risk-Free Interest Rate – The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of option. Expected Dividend – The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero. Net Loss Per Share Net loss per share attributable to common stockholders is computed using the two-class method required for multiple classes of common stock and participating securities. The Company’s participating securities included the Company’s convertible preferred stock and preferred stock. Neither the holders of convertible preferred stock, preferred stock nor the holders of the Company’s common stock warrants have a contractual obligation to share in losses. Basic net loss per share attributable to common stockholders is calculated by dividing the net loss, as adjusted for any dividends on the preferred stock for the period, attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, adjusted for outstanding shares that are subject to repurchase or outstanding shares that are contingently returnable by the holder. Contingently issuable shares, including shares that are issuable for little or no cash consideration, are considered outstanding common shares and included in net loss per share as of the date that all necessary conditions have been satisfied. Such shares include outstanding penny warrants and shares issuable to Xeriant Inc. ("Xeriant") related to the the joint venture arrangement that expired on May 31, 2023. Diluted net loss per share is computed by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. For periods in which the Company reports net losses, diluted net loss per common share attributable to common stockholders is the same as basic net loss per common share attributable to common stockholders, because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. Segments The Company and its Chief Executive Officer ("CEO"), acting as the Chief Operating Decision Maker ("CODM") determined its operating segments in accordance with ASC 280, "Segment Reporting" ("ASC 280"). The Company is organized and operates as two business segments based on similar economic characteristics, the nature of products and production processes, end-use markets, channels of distribution, and regulatory environments. Recently Issued and Adopted Accounting Standards In July 2023, the FASB issued ASU 2023-03, "Presentation of Financial Statements (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718)", which updates codification on how an entity would apply the scope guidance in paragraph 718-10-15-3 to determine whether profits interest and similar awards should be accounted for in accordance with Topic 718, Compensation—Stock Compensation. The effective date of this update is for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2023-03 as of January 1, 2024. The adoption of this guidance did not have a material impact on the condensed consolidated financial statements and disclosures. Recently Issued Accounting Standards Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the chief operating decision maker. The standard is effective for the Company beginning in fiscal year 2024 and interim periods within fiscal year 2025, with early adoption permitted. The Company does not expect to early adopt the new standard. The Company is currently evaluating the impact of ASU 2023-07 on its financial statements and related disclosures. In December 2023, the FASB also issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for the Company for annual periods beginning after December 15, 2024, with early adoption permitted. The Company does not expect to early adopt the new standard. The new standard is expected to be applied prospectively, but retrospective application is permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements and related disclosures.

Disaggregation of Revenue and D

Disaggregation of Revenue and Deferred Revenue	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue and Deferred Revenue	Disaggregation of Revenue and Deferred Revenue Disaggregation of Revenue The Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from software as a service, design and implementation services for its Indoor Intelligence systems, and professional services for work performed in conjunction with its systems recognition policy. Revenues consisted of the following (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Recurring revenue Software $ 327 $ — $ 697 $ — Total recurring revenue $ 327 $ — $ 697 $ — Non-recurring revenue Hardware $ 422 $ — $ 1,190 $ — Software 77 — 82 — Professional services 92 — 200 — Total non-recurring revenue $ 591 $ — $ 1,472 $ — Total Revenue $ 918 $ — $ 2,169 $ — For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenue recognized at a point in time Industrial IoT (1) $ 499 $ — $ 1,272 $ — Total $ 499 $ — $ 1,272 $ — Revenue recognized over time Industrial IoT (2) (3) $ 419 $ — $ 897 $ — Total $ 419 $ — $ 897 $ — Total Revenue $ 918 $ — $ 2,169 $ — (1) Hardware and Software's performance obligation is satisfied at a point in time when they are shipped to the customer. (2) Professional services are also contracted on the fixed fee and time and materials basis. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date, in which revenue is recognized over time. (3) Software As A Service Revenue's performance obligation is satisfied evenly over the service period using a time-based measure because the Company is providing continuous access to its service and revenue is recognized over time. Deferred revenue As of December 31, 2023, the Company did not have any deferred revenue. As part of the XTI Merger, the Company acquired approximately $0.8 million of deferred revenue, all of which relates to RTLS maintenance agreements. The Company's deferred revenue balance of $0.5 million as of September 30, 2024 related to cash received in advance for product maintenance services and professional services provided by the Company’s technical staff. The fair value of the deferred revenue approximates the services to be rendered. The Company expects to satisfy its remaining performance obligations for these maintenance services and professional services, and recognize the deferred revenue and related contract costs over the next twelve months.

Merger Transaction

Merger Transaction	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Merger Transaction	Merger Transaction The XTI Merger was accounted for as a reverse merger in accordance with GAAP. Under this method of accounting, Legacy Inpixon was treated as the "acquired" company for financial reporting purposes. This determination is primarily based on the fact that subsequent to the XTI Merger, Legacy XTI maintains control of the Board of Directors and management of the Company, and the preexisting shareholders of Legacy XTI have majority voting rights of the Company. For accounting purposes, the acquirer is the entity that has obtained control of another entity and, thus, consummated a business combination. Accordingly, Legacy XTI’s assets and liabilities are recorded at carrying value and the assets and liabilities associated with Legacy Inpixon are recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair value of the net assets acquired, if applicable, is recognized as goodwill. The below summarizes the total consideration transferred in the business combination (in thousands): Fair value of common stock $ 10,939 Fair value of warrants 3,250 Fair value of preferred stock 11,302 Fair value of debt assumed 114 Total consideration $ 25,605 The Company determined the estimated fair value of common stock included in consideration to be calculated based on Legacy Inpixon’s common stock outstanding of 2,075,743 multiplied by the price of Legacy Inpixon’s common stock on March 12, 2024 of $5.27 (which reflects the 1 to 100 reverse stock split which became effective before the closing of the XTI Merger). The Company utilized Legacy Inpixon's common stock price in determining fair value as it is more reliably measurable than the value of Legacy XTI’s (accounting acquirer) equity interests given it is not a publicly traded entity. The aggregate fair value of warrants was approximately $3.3 million was included in the total equity consideration. A portion of this total represents 918,689 warrants outstanding by the Company with a fair value of $1.00 per warrant, which is the warrant's redemption value. The warrant fair value was determined to be the redemption value as the warrants include protective covenants for the Company which prevent the holder from exercising the warrants. The remainder of this total represents 491,310 warrants with a fair value of $4.75 per warrant which was determined by using level 3 inputs and utilizing a Black-Scholes valuation. Significant inputs related to these warrants are as follows: Fair value of common stock $ 5.27 Exercise price $ 5.13 Expected term 4.76 years Volatility 146 % Risk-free interest rate 4.2 % Dividend yield — % The fair value of preferred stock of approximately $11.3 million included in the total equity consideration represents 11,302 shares of a new series of Preferred Stock that was issued and outstanding by the Company upon the consummation of the XTI Merger at a stated value and fair value of $1,000 per share. The Company has determined preliminary fair values of the assets acquired and liabilities assumed in the XTI Merger. These values are subject to change as the Company performs additional reviews of its assumptions utilized. The Company has made a provisional allocation of the purchase price of the XTI Merger to the assets acquired and the liabilities assumed as of the purchase date. The following table summarizes the preliminary purchase price allocations relating to the XTI Merger (in thousands): Assets acquired Cash and cash equivalents $ 2,968 Accounts receivable 696 Notes and other receivables 7,929 Inventory 3,283 Prepaid assets and other current assets 756 Property and equipment 246 Other assets 1,202 Warrant assets 448 Tradename & trademarks 913 Proprietary technology 2,934 Customer relationships 702 In process research and development 243 Goodwill 12,398 34,718 Liabilities assumed Accounts payable 2,675 Accrued liabilities 4,282 Operating lease obligation 299 Deferred revenue 824 Short-term debt 114 Warrant liability 919 Total liabilities assumed 9,113 Estimated fair value of assets acquired $ 25,605 The assets were valued using a combination of a multi-period excess earnings methodologies, a relief from royalty approach, a discounted cash flow approach and present value of cash flows approach. The goodwill represents the excess fair value after the allocation of intangibles. As a nontaxable transaction, the historical tax bases of the acquired assets, liabilities and tax attributes have carried over. Although no new tax goodwill has been created in the transaction, the Company has approximately $5.8 million of tax deductible goodwill that arose in previous transactions which carries over. For the nine months ended September 30, 2024 and 2023, the Company incurred merger related transaction costs of approximately $6.5 million and $1.4 million, respectively.

Proforma Financial Information

Proforma Financial Information	9 Months Ended
	Sep. 30, 2024
Business Acquisition, Pro Forma Information [Abstract]
Proforma Financial Information	Proforma Financial Information Inpixon Financial Information The following unaudited proforma financial information presents the consolidated results of operations of the Company and Legacy Inpixon for the nine months ended September 30, 2024 and 2023, as if the acquisition had occurred as of the beginning of the first period presented (January 1, 2023) instead of on March 12, 2024. The proforma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during those periods. The proforma financial information for the Company and Legacy Inpixon is as follows (in thousands): For the Three Months Ended September 30, 2024 For the Three Months Ended September 30, 2023 Revenues $ 918 $ 759 Net loss attributable to common stockholders $ (4,674) $ (9,944) Net loss per basic and diluted share $ (0.13) $ (1.17) Weighted average common shares outstanding: Basic and Diluted 34,986,105 8,476,635 The proforma financial information for the Company and Legacy Inpixon is as follows (in thousands): For the Nine Months Ended September 30, 2024 For the Nine Months Ended September 30, 2023 Revenues $ 2,676 $ 3,486 Net loss attributable to common stockholders $ (36,571) $ (28,397) Net loss per basic and diluted share $ (1.83) $ (3.35) Weighted average common shares outstanding: Basic and Diluted 20,006,531 8,475,135

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill In connection with the XTI and Inpixon Merger, the excess of the purchase price over the estimated fair value of the net assets assumed of $12.4 million was recognized as goodwill. The Company tests goodwill for impairment at the reporting unit level annually or more frequently if a change in circumstances or the occurrence of events indicates that potential impairment exists. In accordance with ASC 350, the Company elected to perform a qualitative assessment as of September 30, 2024, to determine if there were any indicators of goodwill impairment that would require a quantitative analysis to be performed. Due to the qualitative analysis, the Company determined that there were no triggering indicators of goodwill impairment during the three months ended September 30, 2024. The following table summarizes the changes in the carrying amount of Goodwill for the nine months ended September 30, 2024 (in thousands): Amount Beginning balance - January 1, 2024 $ — Goodwill recognized in connection with XTI Merger - Note 5 12,398 Foreign currency translation adjustment 340 Ending balance - September 30, 2024 $ 12,738 Intangible Assets Intangible assets at September 30, 2024 and December 31, 2023 consisted of the following (in thousands): September 30, 2024 Gross Amount Accumulated Amortization Net Carrying Amount Remaining Weighted Average Useful Life Patents $ 452 $ (176) $ 276 9.7 Trade Name/Trademarks 945 (103) 842 4.5 Proprietary Technology 3,012 (237) 2,775 6.5 Customer Relationships 721 (79) 642 4.5 In-Process R&D 243 — 243 3.0 Total $ 5,373 $ (595) $ 4,778 December 31, 2023 Gross Amount Accumulated Amortization Net Carrying Amount Patents $ 413 $ (155) $ 258 Trade Name/Trademarks 8 — 8 Total $ 421 $ (155) $ 266 Amortization expense for the three and nine months ended September 30, 2024 was approximately $0.20 million and $0.43 million, respectively. Amortization expense for the three and nine months ended September 30, 2023 was approximately $0.01 million and $0.02 million, respectively. Future amortization expense on intangibles assets is anticipated to be as follows (in thousands): Amount December 31, 2024 (for 3 months) $ 198 December 31, 2025 873 December 31, 2026 873 December 31, 2027 873 December 31, 2028 792 December 31, 2029 and thereafter 1,169 Total $ 4,778

Other Balance Sheet Information

Other Balance Sheet Information	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Other Balance Sheet Information	Other Balance Sheet Information Prepaid expenses and other current assets Prepaid expenses and other current assets as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): As of September 30, 2024 As of December 31, 2023 AVX deposit - related party $ 523 $ — Prepaid insurance 460 13 Other 340 — Fulfillment costs 286 — Prepaid software 95 90 Deposits — 22 Total prepaid expenses and other current assets $ 1,704 $ 125 Inventory The Company did not hold any inventory as of December 31, 2023. Inventory as of September 30, 2024 consisted of the following (in thousands): As of September 30, 2024 Raw materials $ 33 Work-in-process 125 Finished goods 2,572 Total inventory $ 2,730 Accrued expenses and other current liabilities Accrued expenses and other current liabilities liabilities as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): As of September 30, 2024 As of December 31, 2023 Accrued transaction bonuses $ 5,782 $ — Accrued compensation and benefits 1,120 649 Accrued bonus and commissions 1,196 305 Accrued other 561 173 Total accrued expenses and other current liabilities $ 8,659 $ 1,127

Debt

Debt	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Debt	Debt The Company's outstanding debt consisted of the following at the periods indicated (in thousands): Short-Term Debt Maturity September 30, 2024 December 31, 2023 Promissory Note - 2023 $ — $ 3,071 Promissory Note - 2023 - related party — 125 Convertible Note - 2021 - related party 1 — 1,079 Convertible Note - 2021 1 — 2,500 Promissory Note - May 1, 2024 5/1/2025 1,419 — Promissory Note - May 24, 2024 5/24/2025 1,386 — Third Party Note Payable - 2023 12/31/2024 42 — Third Party Note Payable - 2024 12/14/2024 129 — Unamortized Discounts (356) (50) Unamortized Loan Costs — (35) Total Short-Term Debt $ 2,620 $ 6,690 Long-Term Debt SBA loan 6/3/2050 $ 65 $ 65 Convertible notes, at fair value 1 — 16,804 Convertible Note - 2017 1 — 1,987 Convertible Note - 2022 1 — 600 Convertible Note - 2023 1 — 300 Unamortized Discounts — (1,210) Total Long-Term Debt $ 65 $ 18,546 1 principal balance was either converted to equity immediately prior to the XTI Merger closing time or subsequently repaid Interest expense on outstanding debt totaled approximately $0.4 million and $0.3 million for the three months ended September 30, 2024 and 2023, respectively. Interest expense on outstanding debt totaled approximately $0.9 million and $0.8 million for the nine months ended September 30, 2024 and 2023, respectively. Promissory Note - 2023 On July 24, 2023, the Company and Legacy XTI entered into a Senior Promissory Note which had an outstanding principal balance of approximately $3.1 million as of December 31, 2023. During the period from January 1, 2024 to March 12, 2024, Legacy Inpixon provided an additional $1.0 million in funding to Legacy XTI. As a result of the XTI Merger, Legacy XTI became a wholly-owned subsidiary of the Company and the outstanding subsidiary debt balance, related parent note receivable balance and accrued interest were eliminated upon the consolidation of the Company's September 30, 2024 balance sheet. Promissory Note - 2023 - related party On January 5, 2023, the Company entered into a promissory note agreement with a member of the Company's board of directors. The note had a principal amount of approximately $0.1 million and accrued interest at a rate of 5% per annum. The note's outstanding principal and accrued interest balances were repaid in full during the second quarter of 2024. Convertible Note - 2021 - related party On October 1, 2023, an existing convertible note entered into on December 31, 2021 by and between the Company and a member of the Company's board of directors was replaced by a new convertible note with a principal balance of approximately $1.1 million and interest rate of 4%. On March 12, 2024, approximately $0.9 million of the note's outstanding balance was converted into shares of the Company's common stock. The Company repaid the remaining balance of the note on April 1, 2024. See Note 10 for more information. Convertible Note - 2021 During 2021, the Company entered into convertible notes with a syndicate of investors. The notes had a combined principal amount of $2.5 million and accrued interest at a rate of 4.0% per annum. As discussed in Note 10, pursuant to the terms of voluntary note conversion letter agreements, approximately $2.5 million of the note's outstanding principal balance and accrued interest were converted into shares of Legacy XTI common stock immediately prior to the closing of the XTI Merger, which converted into shares of the Company's common stock at the closing of the XTI Merger on March 12, 2024. A repayment obligation remained after the XTI Merger closing with respect to approximately $0.05 million in principal, which was repaid during the second quarter of 2024, and $0.25 million in accrued interest which remained outstanding as of September 30, 2024. Promissory Note - May 1, 2024 On May 1, 2024 (the "Closing Date"), the Company entered into a note purchase agreement (the "Purchase Agreement") with Streeterville Capital, LLC (the "Holder"), pursuant to which the Company issued and sold to the Holder a secured promissory note (the "Note") in an initial principal amount of approximately $1.4 million, which is payable on or before the date that is 12 months from the issuance date. The Purchase Agreement provides that, subject to the mutual consent of the Company and the Holder, the Holder would purchase an additional secured promissory note on the date that is 30 days from the Closing Date and another secured promissory note on the date that is 60 days from the Closing Date. The initial principal amount of the Note includes an original issue discount of approximately $0.3 million. In exchange for the Note, the Holder paid an aggregate purchase price to the Company of $1.0 million. Interest on the Note accrues at a rate of 10.0% per annum and is payable on the maturity date or otherwise in accordance with the Note. The effective interest rate is 10.5%. If the Note is still outstanding on the date that is six months from the issuance date, then a one-time monitoring fee equal to 10% of the then-current outstanding balance will be added to the outstanding balance of the Note. Beginning on the date that is six months from the issuance date and at monthly intervals until the Note is paid in full, the Holder will have the right to require the Company to redeem up to an aggregate of one sixth of the initial principal balance of the Note plus any interest accrued thereunder each month (each monthly exercise, a “Monthly Redemption Amount”) by providing written notice; provided, however, that if the Holder does not exercise any Monthly Redemption Amount in its corresponding month then such Monthly Redemption Amount will be available for the Holder to redeem in any future month in addition to such future month’s Monthly Redemption Amount. Upon receipt of any Monthly Redemption Notice, the Company will be required to pay the applicable Monthly Redemption Amount in cash to the Holder within five The Company’s obligations under the Note, the additional secured promissory note issued by the Company to the Holder on May 24, 2024 (as described below) and the other transaction documents are secured by (i) a pledge of all of the stock the Company owns in Legacy XTI and (ii) those assets owned by Legacy XTI constituting Collateral (as defined in a security agreement by and between Legacy XTI and the Holder). Additionally, Legacy XTI provided a guarantee of the Company's obligations to the Holder under the Note, the additional secured promissory note and the other transaction documents. Promissory Note - May 24, 2024 Pursuant to the terms of the Purchase Agreement, on May 24, 2024, the Company issued and sold to Streeterville Capital, LLC an additional secured promissory note in the initial principal amount of $1.3 million, which carries an original issue discount of $0.3 million. The terms of this additional note are identical to the terms of the May 1, 2024 note, as described above. In exchange for the promissory note, the Holder paid an aggregate purchase price of $1.0 million. Third Party Note Payable - 2023 - financing agreement As part of the XTI Merger, the Company acquired a financing agreement whereby the lender paid a Company vendor approximately $0.1 million for a service contract. The terms of the agreement are for a 12 months period with a 18.6% interest rate whereby there is no payment due for the first 4 months. After this period, the Company is required to make equal monthly payments over 8 months until the debt is repaid in full. Third Party Note Payable - 2024 - financing agreement On March 14, 2024, the Company entered into a financing agreement whereby the lender paid a Company vendor approximately $0.4 million for an insurance contract. The terms of the agreement are for a 9 month period with a 8.3% interest rate. The Company is required to pay equal amounts per month until the debt is repaid in full. SBA Loan

Common Stock

Common Stock	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Common Stock	Common Stock Capital Raises At-the-Market (ATM) Program On June 14, 2024, the Company entered into Amendment No. 6 to the Equity Distribution Agreement (the "Amendment") with Maxim Group LLC ("Maxim") which amends the Equity Distribution Agreement, dated as of July 22, 2022, between the Company and Maxim, as previously amended (as amended, the "Equity Distribution Agreement"), pursuant to which the aggregate gross sales amount under the Equity Distribution Agreement was increased from approximately $48.8 million to approximately $83.8 million. Accordingly, pursuant to the Equity Distribution Agreement, the Company may, from time to time, sell shares of the Company’s common stock, par value $0.001 per share, having an aggregate gross sales amount of up to approximately $83.8 million through Maxim, as the Company’s exclusive sales agent (the "ATM Offering"). Maxim is entitled to compensation at a fixed commission rate of 3.0% of the gross sales price per Share sold excluding Maxim's costs and out-of-pocket expenses incurred in connection with its services, including the fees and out-of-pocket expenses of its legal counsel. During the three months ended September 30, 2024, the Company sold 3,190,727 shares of common stock under the Equity Distribution Agreement at per share prices between approximately $0.19 and $0.43, resulting in net proceeds to the Company of approximately $1.0 million. During the nine months ended September 30, 2024, the Company sold 12,490,930 shares of common stock under the Equity Distribution Agreement at per share prices between approximately $0.19 and $1.35, resulting in net proceeds to the Company of approximately $9.6 million. Since the date of the Equity Distribution Agreement through the date of this report, the Company sold 101,704,300 shares of common stock at per share prices between approximately $0.06 and $1.86 under the Equity Distribution Agreement, resulting in gross proceeds of approximately $45.2 million. As of the date of this report, there was approximately $38.6 million in common stock gross sales remaining under the Equity Distribution Agreement, subject to the limitations set forth in the Series 9 ATM Consent (as defined below). In connection with the Amendment and in accordance with the terms of the Certificate of Designation of Preferences and Rights of the Company's Series 9 Preferred Stock (the "Certificate of Designation"), on June 14, 2024, the Company obtained a written consent (the "Series 9 ATM Consent") from the Required Holders (as defined below). The Series 9 ATM Consent provides that the Company may not register shares under the ATM Offering in excess of $47.4 million (the "ATM Maximum Amount") without the Required Holders’ prior written consent, and the Company may not issue or sell more than $6 million of additional shares of common stock pursuant to the ATM Offering (the "Initial Tranche") without the Required Holders’ prior written consent, which consent the Company is required to obtain for each additional $5 million in sales of common stock under the ATM Offering after the Initial Tranche up to the ATM Maximum Amount. "Required Holders" is defined in the Certificate of Designation as the holders of at least a majority of the outstanding Series 9 Preferred Stock; provided that, pursuant to that certain securities purchase agreement dated as of March 12, 2024, between the Company and 3AM Investments LLC (an entity controlled by the Company's former director and former Chief Executive Officer, Nadir Ali) (the "Purchaser"), the Purchaser will be deemed a "Required Holder" as defined in the Certificate of Designation as long as the Purchaser holds any shares of Series 9 Preferred Stock. Note Conversion Immediately prior to the effective time of the XTI Merger on March 12, 2024, certain convertible notes (collectively classified as "convertible notes, at fair value") with an aggregate principal and interest balance of $16.8 million were converted into Legacy XTI shares, which converted into an aggregate of 751,226 shares of the Company's common stock at the effective time of the XTI Merger. Immediately prior to the conversion, the convertible notes, at fair value were marked to market resulting in a gain of $12.9 million, which is included in change in fair value of convertible notes in the other income and expense section of the condensed consolidated statement of operations. As a result of the conversions, the notes were satisfied in full and therefore relieved the Company of all obligations. Note Inducements To induce certain note holders to convert their outstanding note balances into shares of Legacy XTI common stock ahead of the XTI Merger, Legacy XTI entered into voluntary note conversion letter agreements in February 2024 as detailed in the below table. Per the letter agreements, some or all of the outstanding principal and accrued interest under the notes was converted at a reduced conversion price into shares of Legacy XTI common stock immediately prior to the XTI Merger closing time, which converted into shares of the Company's common stock upon the closing of the XTI Merger. In connection with some of the voluntary note conversions, the Company assumed a repayment obligation with respect to any outstanding balance under the notes that was not converted into Legacy XTI shares. The Company accounted for these conversions as an inducement and recognized a loss related to the fair value of the additional shares issued compared to the original terms of the convertible note, which is included in inducement loss on debt conversions in the other income and expense section of the condensed consolidated statement of operations. The following table details the notes converted into shares of Legacy XTI common stock (in thousands, except conversion price). Letter Agreement Aggregate Principal and Interest Outstanding Immediately Prior to XTI Merger Aggregate Principal and Interest Converted to Common Shares Reduced Conversion Price Post - Exchange Ratio Common Shares Outstanding Payment Obligation Immediately After XTI Merger Net Inducement Charge Convertible Note 2021 $ 2,777 $ 2,504 $ 0.265 844 $ 273 $ 3,266 Convertible Note 2017 $ 2,148 $ 2,148 $ 0.265 724 $ — $ 2,795 Convertible Note 2022 $ 682 $ 600 $ 0.265 202 $ 82 $ 464 Convertible Note 2023 $ 333 $ 300 $ 0.265 101 $ 33 $ 207 Totals $ 5,940 $ 5,552 1,871 $ 388 $ 6,732 Note Inducement: Convertible Note 2021 - Related Party To induce David Brody, a board member and founder of Legacy XTI, to convert his outstanding note balances into shares of Legacy XTI common stock, Legacy XTI entered into a voluntary note conversion letter agreement with the note holder in February 2024. Per the letter agreement, $0.9 million of the outstanding note balance was converted at a reduced conversion price of $0.309 into shares of Legacy XTI common stock immediately prior to the XTI Merger closing time equal to 266,272 shares of the Company's common stock, and the Company assumed the obligation to pay the note holder $0.2 million of the note balance that was not converted into Legacy XTI shares. This repayment obligation was subsequently paid in full on April 1, 2024. The Company accounted for this conversion as an inducement and recognized an inducement charge of $1.0 million related to the fair value of the additional shares issued compared to the original terms of the convertible note. As this note holder is a related party of the Company, the Company accounted for the conversion as a capital transaction and therefore recorded the inducement charge within additional paid in capital. Share Issuances At or Immediately Prior to XTI Merger Closing At the closing of the XTI Merger, 2,075,743 shares of the Company's common stock were issued to Legacy Inpixon’s preexisting shareholders as consideration for the transaction. Shares of Legacy XTI common stock were issued to Xeriant immediately prior to the XTI Merger closing time, equal to 298,395 post merger shares of Company common stock. This share issuance to Xeriant fully settled the obligation relating to a joint venture arrangement by and between Legacy XTI and Xeriant which terminated by its terms on May 31, 2023. The obligation to issue shares to Xeriant was classified in equity as of December 31, 2023, as the share consideration became fixed once the joint venture terminated. Other Share Issuances On June 6, 2024, the Company entered into a consulting agreement with a third party consultant, which has a term until December 10, 2024, pursuant to which the Company made a cash deposit of $0.1 million and issued 309,483 shares of restricted common stock valued at approximately $0.3 million to the consultant as a prepayment for marketing and distribution services agreed to be rendered to the Company over the six-month contract period. On June 7, 2024, the Company entered into a consulting agreement with a separate third party consultant, which has a term of six months, pursuant to which the Company issued 120,000 shares of restricted common stock valued at approximately $0.1 million to the consultant as a prepayment for business development consulting services agreed to be rendered to the Company over the six-month contract period. On June 13, 2024 and July 5, 2024, the Company issued 2,680,459 shares valued at $1.2 million and 2,774,883 shares valued at $1.1 million, respectively, of fully vested restricted stock to Nadir Ali, a consultant, under the Company’s 2018 Employee Stock Incentive Plan, as amended, as payment of accrued consulting fees in accordance with the terms of a consulting agreement, dated March 12, 2024, by and between the Company and Mr. Ali. On July 31, 2024, the Company entered into an advisory agreement with a third party advisor, pursuant to which the Company issued 1,000,000 shares valued at $0.3 million of restricted common stock to the advisor in consideration for financial advisory and business development services agreed to be rendered to the Company pursuant to the agreement.

Preferred Stock

Preferred Stock	9 Months Ended
	Sep. 30, 2024
Preferred Stock [Abstract]
Preferred Stock	Preferred Stock The Company is authorized to issue up to 5,000,000 shares of preferred stock with a par value of $0.001 per share with rights, preferences, privileges and restrictions as to be determined by the Company’s Board of Directors. Series 9 Preferred Stock On March 12, 2024, the Company filed the Certificate of Designations of Preferences and Rights of Series 9 Preferred Stock (the “Certificate of Designation”), with the Secretary of State of Nevada, designating 20,000 shares of preferred stock, par value $0.001 of the Company, as Series 9 Preferred Stock, which was amended by the Certificate of Amendment to Designations of Preferences and Rights of Series 9 Preferred Stock filed by the Company with the Secretary of State of Nevada on April 30, 2024. Each share of Series 9 Preferred Stock has a stated face value of $1,050 (“Stated Value”) and do not have any voting rights. Preferred stock is recorded on the accompanying consolidated balance sheet at its redemption value which is the carrying value of the redeemable preferred stock. Each share of Series 9 Preferred Stock will accrue a rate of return on the Stated Value in the amount of 10% per year, compounded annually to the extent not paid, and pro rata for any fractional year periods (the “Preferred Return”). The Preferred Return will accrue on each share of Series 9 Preferred Stock from the date of issuance and will be payable on a quarterly basis, either in cash or through the issuance of an additional number of shares of Series 9 Preferred Stock equal to (i) the Preferred Return then accrued and unpaid, divided by (ii) the Stated Value, at the Company’s discretion. The Preferred Stock holders will also receive a quarterly dividend at 2% per quarter, beginning on the one-year anniversary of the issuance date and for all periods following the two-year anniversary of the issuance date of a share of Series 9 Stock, the dividend shall be 3% per quarter. The Company may elect, in the sole discretion of the Board, to redeem all or any portion of the Series 9 Stock then issued and outstanding from all of the Series 9 Holders by paying to the applicable Series 9 Holders an amount in cash equal to the liquidation amount as defined in the preferred stock agreement. Exchange Agreement On March 12, 2024, Inpixon and Streeterville Capital, LLC (the “Note Holder” or “Streeterville”), the holder of an outstanding promissory note issued on December 30, 2023 (as amended, the “December 2023 Note”), entered into an Exchange Agreement, pursuant to which the Note Holder exchanged the remaining balance of principal and accrued interest under the December 2023 Note in the aggregate amount of approximately $9.8 million for 9,802 shares of Series 9 Preferred Stock (the “Preferred Stock”), based on an exchange price of $1,000 per share of Series 9 Preferred Stock. The Company analyzed the exchange of the principal and interest as an extinguishment and compared the net carrying value of the debt being extinguished to the reacquisition price (shares of preferred stock being issued). The Company notes that the net carrying value of the debt was the fair value of the preferred stock (reacquisition price). As such, no gain or loss was recognized upon debt extinguishment. Following such exchange and the extinguishment of the December 2023 Note, the December 2023 Note is deemed paid in full, automatically canceled, and will not be reissued. Securities Purchase Agreement On March 12, 2024, Legacy Inpixon entered into a securities purchase agreement (the “Securities Purchase Agreement”) with 3AM Investments, LLC ("3AM"), an entity controlled by Legacy Inpixon’s former director and former Chief Executive Officer, Nadir Ali (such entity, the "Purchaser"). Pursuant to the Securities Purchase Agreement, the Purchaser purchased 1,500 shares of Series 9 Preferred Stock for a total purchase price of approximately $1.5 million, based on a purchase price of $1,000 per share of Series 9 Preferred Stock. The Company agreed that the Purchaser will be deemed a “Required Holder” as defined in the Certificate of Designation as long as the Purchaser holds any shares of Series 9 Preferred Stock. The Securities Purchase Agreement sets forth certain restrictions on the Company’s use of the proceeds from the sale of the Series 9 Preferred Stock pursuant thereto, including that the proceeds must be used in connection with the redemption of the Series 9 Preferred Stock pursuant to the Certificate of Designation or working capital purposes, and may not, without the consent of the required holders of Series 9 Preferred Stock, be used for, among other things, (i) the redemption of any XTIA common stock or common stock equivalents, (ii) the settlement of any outstanding litigation, or (iii) for the repayment of debt for borrowed money to any officer or director, or Merger-transaction related bonuses to any employee or vendor except for such non-merger transaction related bonuses as may be payable to participants pursuant to the Company’s existing employee bonus plan. In connection with the issuance of the Preferred Stock, the direct and incremental expenses incurred were immaterial. Amendment to Series 9 Preferred Stock The Certificate of Amendment to Designations of Preferences and Rights of Series 9 Preferred Stock (the “Certificate of Amendment”) allows the Company to pay the holders of Series 9 Preferred Stock, if such holders agree, with securities or other property of the Company in an amount equal to the Series 9 Preferred Liquidation Amount (as defined in the Series 9 Preferred Stock Certificate of Designation) in the event the Company elects to redeem all of any portion of the Series 9 Preferred Stock then issued and outstanding (a “Corporation Optional Redemption”). Previously, the Company was to pay any such amount in only cash. The Certificate of Amendment also now provides that the Company will provide notice of a Corporation Optional Redemption to the holders of Series 9 Preferred Stock within five business days prior to the consummation of such redemption rather than five business days following the determination of the Company’s board of directors to consummate such redemption. In addition, the Certificate of Amendment eliminates the requirement for the Company to obtain the written consent of the holders of at least a majority of the outstanding Series 9 Preferred Stock before repaying any outstanding indebtedness owed to any holder of Series 9 Preferred Stock or its affiliates. The Company evaluated the amendment and accounted for it as a modification, which requires the Company to recognize any increase in fair value as an expense. However, the Company concluded the increase in the fair value of the Series 9 Preferred Stock from immediately before to immediately after the amendment is immaterial. Series 9 Preferred Stock Exchanges From April through September 2024, the Company entered into exchange agreements with the holder of shares of the Company’s Series 9 Preferred Stock pursuant to which the Company and the holder agreed to exchange 4,625 shares of Series 9 Preferred Stock with an aggregate stated value of $4,856,250 (the “Preferred Shares”) for 7,196,000 shares of common stock (the “Preferred Exchange Shares”) at an effective price per share ranging from $0.2085 to $2.96. The Company issued the Preferred Exchange Shares to the holder, at which time the Preferred Shares were cancelled. The Preferred Exchange Shares were issued in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act, on the basis that (a) the Preferred Exchange Shares were issued in exchange for other outstanding securities of the Company, (b) there was no additional consideration delivered by the holder in connection with the exchange and (c) there were no commissions or other remuneration paid by the Company in connection with the exchange. The Company notes that the redemption of the Preferred Shares to Common Stock was accounted for as an extinguishment. During the three and nine months ending September 30, 2024, the Company recognized a deemed dividend of $53,750 and $230,730, respectively. The deemed dividends represented the excess fair value of the common shares issued over the carrying amount of the Preferred Shares and were accounted for as a reduction to additional paid-in capital.

Stock Award Plans and Stock-Bas

Stock Award Plans and Stock-Based Compensation	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock Award Plans and Stock Based Compensation	Stock Award Plans and Stock-Based Compensation The Company has three Employee Stock Incentive plans. The Company assumed Legacy XTI's 2017 Employee and Consultant Stock Ownership Plan (the "2017 Plan") in connection with the XTI Merger. Legacy Inpixon had put in place a 2011 Employee Stock Incentive Plan (the "2011 Plan") and a 2018 Employee Stock Incentive Plan (the "2018 Plan" and together with the 2011 Plan, the "Legacy Inpixon Option Plans"). The Company determined that activity within the 2011 Plan is not material. 2017 Plan During 2017, Legacy XTI adopted the 2017 Plan, which was amended in 2021 to increase the maximum shares eligible to be granted under the 2017 Plan. The Company may issue awards in the form of restricted stock units and stock options to employees, directors, and consultants. Under the 2017 Plan, stock options are generally granted with an exercise price equal to the estimated fair value of the Company’s common stock, as determined by the Company’s Board of Directors on the date of grant. Options generally have contractual terms of ten years. Incentive stock options (ISO) may only be granted to employees, whereas all other stock awards may be granted to employees, directors, consultants and other key stakeholders. As of September 30, 2024, there are no unallocated shares available for future grants under the 2017 Plan. 2018 Plan In February 2018, Legacy Inpixon adopted the 2018 Plan which is utilized for employees, corporate officers, directors, consultants and other key persons employed. The 2018 Plan provides for the granting of incentive stock options, NQSOs, stock grants and other stock-based awards, including Restricted Stock and Restricted Stock Units (as defined in the 2018 Plan). As of September 30, 2024, there are no unvested Restricted Stock or Restricted Stock Units outstanding under the 2018 Plan. Incentive stock options granted under the Legacy Inpixon Option Plans are granted at exercise prices not less than 100% of the estimated fair market value of the underlying common stock at date of grant. The exercise price per share for incentive stock options may not be less than 110% of the estimated fair value of the underlying common stock on the grant date for any individual possessing more that 10% of the total outstanding common stock of the Company. Options granted under these Legacy Inpixon Option Plans vest over periods ranging from immediately to four years and are exercisable over periods not exceeding ten years. The aggregate number of shares that may be awarded under the 2018 Plan as of September 30, 2024 was 67,148,179. As of September 30, 2024, 52,370,064 shares of common stock were available for future grant under the 2018 Plan. See below for a summary of the stock options granted under the 2011, 2017, and 2018 plans: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Aggregate Intrinsic Value (In millions) Beginning balance as of January 1, 2024 1,161,687 $ 17.95 6.7 $ — Legacy Inpixon stock options from merger 1,148 61.67 Granted 12,565,606 0.47 Exercised (92,718) 0.00 Expired (242) 19,043.35 Forfeited (853,299) 8.83 Ending balance as of September 30, 2024 12,782,182 $ 1.87 9.6 $ — Options vested and exercisable as of September 30, 2024 852,174 15.13 7.6 — Forfeitures during the nine months ended September 30, 2024 were primarily due to the departure of Legacy XTI's former Chief Executive Officer. The Board approved awards of options to certain Company executives under the 2018 Plan. Each option has an exercise price of $0.473 per share. The options will vest 1/3rd annually over three years starting from the vesting commencement date. The options expire ten years from the grant date. Options were granted as follows: Grantee Grant Date Vesting Start Date Options Granted Chief Executive Officer of XTI Aerospace, Inc. 6/12/2024 6/12/2024 2,812,500 Chief Financial Officer of XTI Aerospace, Inc. 6/12/2024 6/12/2024 1,640,625 Chief Executive Officer of the XTI Aerospace, Inc. Real-Time Location System Division 6/12/2024 6/12/2024 975,000 Chief Strategy Officer of XTI Aerospace, Inc. 9/19/2024 8/1/2024 1,171,875 Total Granted 6,600,000 The following assumptions were used in estimating the fair values of options awarded during the nine months ended September 30, 2024: Fair value of common stock $0.191 - $0.473 Exercise price $0.191 - $0.473 Expected term 10.0 years Volatility 95.06% - 96.17% Risk-free interest rate 3.58% - 4.32% Dividend yield — % Stock Option Exercises To induce option holders to exercise stock options ahead of the XTI Merger so to assist the Company in qualifying for a listing on the Nasdaq Capital Market, Legacy XTI entered into exercise letter agreements with several option holders in February 2024 at reduced exercise prices from the original option agreements. The net impact of these option inducements to the condensed consolidated statement of operations was not material. In total, 1,038,871 stock option granted under the 2017 Plan were net exercised into pre-exchange common shares of Legacy XTI immediately prior to the XTI Merger closing time, which resulted in the issuance of 92,728 post merger exchange common shares. Stock-based Compensation Expense The Company incurred the following stock-based compensation charges for the periods indicated below (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Employee and consultant stock options 1 $ (2,159) $ 164 $ (2,075) $ 2,766 Professional fees 1 270 — 270 — Vesting of previously unvested warrants 2 — — 496 — Merger-related professional fees 2 — — 5,153 — Total $ (1,889) $ 164 $ 3,844 $ 2,766 1 amount included in general and administrative expenses on the condensed consolidated statements of operations 2 amount included in merger-related transaction costs on the condensed consolidated statements of operations As of September 30, 2024, the total unrecognized compensation expense related to unvested awards was $6.4 million, which the Company expects to recognize over an estimated weighted average period of 1.94 years. Stock-based Compensation Related to the XTI Merger Shares of Legacy XTI common stock were issued to Scott Pomeroy, Chief Executive Officer of the Company and former CFO and board member of Legacy XTI, as transaction compensation immediately prior to the XTI Merger closing time equal to 357,039 post merger shares of Company common stock. As a result of this share issuance transaction, the Company recorded $1.9 million of stock-based compensation expense included in the condensed consolidated statement of operations during the nine months ended September 30, 2024. Shares of Legacy XTI common stock were issued to Maxim as transaction compensation immediately prior to the XTI Merger closing time equal to 385,359 post merger shares of Company common stock. As a result of this share issuance transaction, the Company recorded $2.03 million of stock-based compensation expense included in the condensed consolidated statement of operations during the nine months ended September 30, 2024. Shares of Legacy XTI common stock were issued to Chardan Capital Markets LLC as transaction compensation immediately prior to the XTI Merger closing time equal to 189,036 post merger shares of Company common stock. As a result of this share issuance transaction, the Company recorded $1.0 million of stock-based compensation expense included in the condensed consolidated statement of operations during the nine months ended September 30, 2024.

Warrants

Warrants	9 Months Ended
	Sep. 30, 2024
Warrants [Abstract]
Warrants	Warrants The following table summarizes the activity of warrants outstanding: Number of Warrants Beginning balance as of January 1, 2024 771,895 Legacy Inpixon warrants from merger 1,448,481 Granted 167,664 Exercised (409,815) Expired (96,659) Exchanged (1,602,630) Ending balance as of September 30, 2024 278,936 Exercisable as of September 30, 2024 89,780 Warrant Exercise Price Reduction On March 21, 2024, the Company’s Board of Directors authorized a reduction in the exercise price of the warrants issued as part of the Legacy Inpixon warrant inducement that occurred on December 15, 2023 from $7.324 to $5.13 per share in accordance with the existing terms of such warrants. As the reduction in exercise price was part of the consideration for the XTI Merger, the Company accounted for the modification as part of its purchase accounting. Warrant Exercises On March 11, 2024, Legacy XTI entered into an amendment (the “Warrant Amendment”) with Mesa Airlines ("Mesa"). The Warrant Amendment modifies the vesting criteria with respect to the shares of common stock underlying the warrant issued by the Company to Mesa pursuant to the conditional aircraft purchase contract described below. As amended by the Warrant Amendment, (i) one-third of the shares represented by the warrant vested upon the execution and delivery of the conditional aircraft purchase contract, dated February 2, 2022, by and between the Company and Mesa, relating to the purchase of 100 TriFan 600 aircraft, (ii) one-sixth of the shares vested on March 12, 2024 in which the Company recorded $0.5 million of stock-based compensation expense for the nine months ended September 30, 2024, (iii) one-sixth of unvested shares lapsed on March 12, 2024, and (iv) one-third or 189,156 shares will vest upon the acceptance of delivery and final purchase of the first TriFan 600 aircraft by Mesa pursuant to the Aircraft Purchase Agreement. On March 12, 2024 and per a warrant exercise letter agreement, all vested warrant shares were net exercised into shares of Legacy XTI common stock immediately prior to the XTI Merger closing time, which resulted in the issuance of 283,737 shares of the Company's common stock in accordance with the exchange ratio pursuant to the XTI Merger Agreement. To induce warrant holders to exercise warrant shares, Legacy XTI entered into exercise letter agreements with several warrant holders in February 2024 at reduced exercise prices from the original warrant agreements. The net impact of these warrant inducements to the condensed consolidated statement of operations was not material. In total, 1,182,522 warrant shares were net exercised into shares of Legacy XTI common stock immediately prior to the XTI Merger closing time, which resulted in the issuance of 105,550 shares of the Company's common stock in accordance with the exchange ratio pursuant to the XTI Merger Agreement. During the second quarter of 2024, an additional 20,528 warrant shares originally issued by Legacy XTI were exercised into 20,528 shares of the Company's common stock at an exercise price of $0.12. Warrant Exchanges On April 30, 2024 and May 1, 2024, the Company entered into warrant exchange agreements with the holders of certain of our then outstanding warrants (the “Existing Warrants”) initially issued on May 17, 2023, which were exercisable for an aggregate of 918,690 shares of our common stock. Pursuant to the terms of the agreements, on May 2, 2024, the Company issued to the warrant holders 0.70 shares of common stock for each Existing Warrant, for an aggregate of 643,082 shares of common stock valued at $1,590,859, in exchange for the Existing Warrants. As the Existing Warrants were liability classified, the exchange resulted in the liability being (i) remeasured at the warrant redemption value of $1,590,859 resulting in a fair value loss of $672,174 which is reported in other income (expense) within the condensed consolidated statements of operations for the nine months ended September 30, 2024, and (ii) reclassified to stockholders' equity (deficit) within the condensed consolidated balance sheet as of September 30, 2024. Following the consummation of the warrant exchange, the Existing Warrants were cancelled and no further shares are issuable pursuant to the Existing Warrants agreement. On May 30, 2024, the Company entered into a warrant exchange agreement with the holder of certain warrants of the Company (the “Assumed Warrants”) to purchase shares of common stock, which Assumed Warrants were originally issued by Legacy XTI and assumed by the Company in connection with the XTI Merger. Pursuant to the terms of the agreement, the Company issued to the warrant holder an aggregate of 112,360 shares of common stock valued at $106,742 in exchange for 192,626 Assumed Warrants, which included 167,664 warrants shares granted during the nine months ended September 30, 2024 as result of price protection clauses per the Assumed Warrant agreements relating to subsequent equity sales by the Company. As the Assumed Warrants were liability classified, the exchange resulted in the liability being (i) remeasured at the warrant redemption value of $106,742 resulting in a fair value loss of $6,742 which is reported in other income (expense) within the condensed consolidated statements of operations for the nine months ended September 30, 2024, and (ii) reclassified to stockholders' equity (deficit) within the condensed consolidated balance sheet as of September 30, 2024. Following the consummation of the warrant exchange, the Assumed Warrants were cancelled and no further shares are issuable pursuant to the Assumed Warrants agreement. On June 12, 2024 and June 13, 2024, the Company entered into warrant exchange agreements with the holders (the “Warrant Holders”) of 491,314 existing warrants of the Company (the “Existing Warrants”) initially issued on December 19, 2023, which were exercisable for an aggregate of 491,314 shares of our common stock. Pursuant to the terms of the agreements, on June 13, 2024, the Company issued to the Warrant Holders 1.50 shares of Common Stock for each Existing Warrant, for an aggregate of 736,973 shares of common stock, in exchange for the Existing Warrants. Following the consummation of the Warrant Exchange, the Existing Warrants were cancelled and no further shares are issuable pursuant to the Existing Warrants agreements. As it relates to the aforementioned Existing Warrants issued on December 19, 2023, there were 663,581 shares of common stock issued on June 12, 2024 for $0.47 per share and 73,392 shares of common stock issued on June 13, 2024 for $0.44 per share. The Warrant Holders received a total value of $344,176 for the conversion of the Existing Warrants to shares of common stock. The Company determined the fair value of the Existing Warrants as if issued on the exchange date and compared that to the fair value of the common stock issued. The Company calculated the fair value of the Existing Warrants using a Black-Scholes Option pricing model and determined the fair value to be approximately $61,000. The inputs to the Black-Scholes Option pricing model for the June 12, 2024 redemption include a dividend rate of 0%, a risk free rate of 4.4%, a stock price of $0.47, strike price of $5.13, term of 4.51, and a volatility of 90.0%. The inputs to the Black-Scholes Option pricing model for the June 13, 2024 redemption include a dividend rate of 0%, a risk free rate of 4.3%, a stock price of $0.44, a strike price of $5.13, a term of 4.51, and a volatility of 91.0%. The fair values of the common stock issued were based on the closing stock price of the date of the exchange.

Segments

Segments	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segments	Segments The Company’s Chief Executive Officer (“CEO”), acting as the Chief Operating Decision Maker, or (“CODM”), regularly reviews and manages certain areas of its businesses, resulting in the Company identifying two reportable segments: Industrial IoT and Commercial Aviation. The Company manages and reports its operating results through these two reportable segments. This allows the Company to enhance its customer focus and better align its business models, resources, and cost structure to the specific current and future growth drivers of each business, while providing increased transparency to the Company’s shareholders. The commercial aviation segment is currently in the pre-revenue development stage and its primary activity is the development of the TriFan 600 aircraft. The Industrial IoT segment generates revenue primarily from the sale of real-time location system solutions for the industrial sector and its customers are primarily located in Germany and the U.S. As it relates to the Industrial IoT segment, the results disclosed in the table below only reflect activity following the XTI Merger closing through the September 30, 2024 reporting date. Gross profit and income (loss) from operations are the primary measures of Industrial IoT segment performance used by the Company’s CODM. The Company notes that Commercial Aviation is in the pre-revenue operating stage, and therefore the CODM primarily focuses on research and development expenses and total loss by operations as the primary measure of Commercial Aviation segment performance used by the Company’s CODM. Unallocated operating expenses include costs that are not specific to a particular segment but are general to the group; included expenses incurred for administrative and accounting staff, general liability and other insurance, accrued consulting fees and transaction bonuses relating to former Legacy Inpixon executives, professional fees and other similar corporate expenses. The following table reflects results of operations from our business segments for the periods indicated below (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenue by Segment Industrial IoT $ 918 $ — $ 2,169 $ — Commercial Aviation — — — — Total segment revenue $ 918 $ — $ 2,169 $ — Gross profit by Segment Industrial IoT $ 520 $ — $ 1,323 $ — Commercial Aviation — — — — Gross profit by Segment $ 520 $ — $ 1,323 $ — Research and Development Expenses by Segment Industrial IoT $ 609 $ — 1,361 — Commercial Aviation 619 472 1,479 1,299 Research and Development Expenses by Segment $ 1,228 $ 472 $ 2,840 $ 1,299 Income (loss) from operations by Segment Industrial IoT $ (1,312) $ — $ (2,788) $ — Commercial Aviation 1,788 (2,378) (7,161) (7,702) Loss from operations by segment $ 476 $ (2,378) $ (9,949) $ (7,702) Unallocated costs (4,692) — (17,071) — Consolidated loss from operations $ (4,216) $ (2,378) $ (27,020) $ (7,702) The following table presents total assets by reportable segment (in thousands): September 30, December 31, 2024 2023 Industrial IoT $ 21,583 $ — Commercial Aviation 1,231 509 Total assets by segment $ 22,814 $ 509 Corporate 6,469 — Total consolidated assets $ 29,283 $ 509 The reporting package provided to the Company's CODM does not include the measure of assets by segment as that information isn't reviewed by the CODM when assessing segment performance or allocating resources.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value Measurements and Fair Value of Financial Instruments The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. Financial instruments consist of cash and cash equivalents, accounts receivable, notes receivable, warrant asset, accounts payable, warrant liability, convertible notes, and the loan conversion derivative. Cash and cash equivalents, accounts receivable and accounts payable are stated at their respective carrying amounts, which approximate fair value due to their short-term nature. The changes in fair value of the warrant liability, convertible notes, and warrant asset are presented within 'Change in fair value of warrant liability', 'Change in fair value of convertible notes', and 'Other expense', respectively, in the condensed consolidated statements of operations. The fair value of the Level 3 warrant liability was determined using a pricing model with certain significant unobservable market data inputs. Damon Motors Convertible Note On October 26, 2023, Legacy Inpixon purchased a convertible note through a private placement in aggregate principal amount of $3.0 million for a purchase price of $3.0 million from Damon Motors Inc. Interest on the convertible note accrues at 12% per annum. The note was subsequently amended. As amended, the note matures on November 30, 2024. The convertible note is subject to certain conversion features which include qualified financing, and/or qualified transaction, as defined in the securities purchase agreement. The note will be required to convert upon Damon Motors Inc. completing a public company event. In addition, Damon Motors Inc. issued a five-year warrant to purchase 1,096,321 shares of Damon Motors Inc. common stock in connection with the note. Management notes the Warrant is freestanding. The exercise price per Common Share is $2.7364. The Warrant provides for cashless exercise after 180 days following the closing of the public company event should there be no effective registration statement. The convertible note receivable is not traded in active markets and its fair value was determined using a present value technique. The convertible note receivable is accounted for as an available-for-sale debt security based on “Level 3” inputs, which consist of unobservable inputs and reflect management’s estimates of assumptions that market participants would use in pricing the asset, with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income (loss). The Warrant is accounted for as an equity security based on “Level 3” inputs, which consist of unobservable inputs and reflect management’s estimates of assumptions that market participants would use in pricing the asset, recorded at fair value with subsequent changes in fair value recorded in earnings. The convertible note's and warrant's values as of September 30, 2024 total $4.0 million and are included in Notes Receivable, $3.6 million, and Warrant asset, $0.4 million, on the condensed consolidated balance sheets. The Company's assets and liabilities measured at fair value consisted of the following at the periods indicated: Fair value at September 30, 2024 Total Level 1 Level 2 Level 3 Assets: Notes receivable $ 3,601 $ — $ — $ 3,601 Warrant asset 424 — — 424 Total assets 4,025 — — 4,025 Fair Value at December 31, 2023 Total Level 1 Level 2 Level 3 Liabilities: Warrant liability $ 497 $ — $ — $ 497 Convertible notes, at fair value 16,804 — — 16,804 Loan conversion derivatives 333 — — 333 Total liabilities 17,634 — — 17,634 The table below provides a summary of changes in the estimated fair value of the Company's Level 3 assets and liabilities: Notes receivable Warrant asset Warrant liability Convertible notes, at fair value Loan conversion derivatives Balance at January 1, 2024 $ — $ — $ 497 $ 16,804 $ 333 Acquired 3,264 448 920 — — Change in fair value — — (398) (12,882) — Exchanged / Conversion to Equity — — — (3,922) (333) Balance at March 31, 2024 $ 3,264 $ 448 $ 1,019 $ — $ — Change in fair value 38 (24) 679 — — Accrued interest 91 — — — — Debt discount recognition 49 — — — — Exchanged / Conversion to Equity — — (1,698) — — Balance at June 30, 2024 $ 3,442 $ 424 $ — $ — $ — Change in fair value 20 — — — — Accrued interest 90 — — — — Debt discount recognition 49 — — — — Balance at September 30, 2024 $ 3,601 $ 424 $ — $ — $ —

Foreign Operations

Foreign Operations	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Foreign Operations	Foreign Operations Prior to the XTI Merger, the Company’s operations were located primarily in the United States. After the XTI Merger, the Company's operations are located primarily in the United States, Germany, and the United Kingdom. Revenues by geographic area are attributed by country of domicile of our subsidiaries. The financial data by geographic area are as follows (in thousands): United Germany United Kingdom Eliminations Total For the Three Months Ended September 30, 2024: Revenues by geographic area $ 435 $ 622 $ — $ (139) $ 918 Operating (loss) income by geographic area $ (3,167) $ (1,049) $ — $ — $ (4,216) Net (loss) income by geographic area $ (3,389) $ (1,046) $ — $ — $ (4,435) For the Three Months Ended September 30, 2023: Revenues by geographic area $ — $ — $ — $ — $ — Operating (loss) income by geographic area $ (2,378) $ — $ — $ — $ (2,378) Net (loss) income by geographic area $ (2,703) $ — $ — $ — $ (2,703) For the Nine Months Ended September 30, 2024: Revenues by geographic area $ 758 $ 1,689 $ — $ (278) $ 2,169 Operating (loss) income by geographic area $ (25,146) $ (1,874) $ — $ — $ (27,020) Net (loss) income by geographic area $ (19,886) $ (1,861) $ — $ — $ (21,747) For the Nine Months Ended September 30, 2023: Revenues by geographic area $ — $ — $ — $ — $ — Operating (loss) income by geographic area $ (7,702) $ — $ — $ — $ (7,702) Net (loss) income by geographic area $ (8,897) $ — $ — $ — $ (8,897) As of September 30, 2024: Identifiable assets by geographic area $ 43,253 $ 23,322 $ 10 $ (37,302) $ 29,283 Long lived assets by geographic area $ 2,086 $ 3,449 $ — $ — $ 5,535 Goodwill by geographic area $ 3,142 $ 9,596 $ — $ — $ 12,738 As of December 31, 2023: Identifiable assets by geographic area $ 509 $ — $ — $ — $ 509 Long lived assets by geographic area $ 278 $ — $ — $ — $ 278 Goodwill by geographic area $ — $ — $ — $ — $ —

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Refer to Note 9 for disclosures on related party debt transactions. David Brody, board member and founder of Legacy XTI, provided legal and strategic consulting services for the Company. During the nine months ended September 30, 2024 and 2023, amounts paid by the Company to Mr. Brody were not significant. The Company had no payables to Mr. Brody at September 30, 2024 and had accrued $0.3 million of fees as of December 31, 2023 which is included in Related Party Payables within the accompanying condensed consolidated balance sheets. Pursuant to an amendment to the consulting agreement, the outstanding payable was waived by Mr. Brody, which was accounted for as a capital contribution, and the consulting agreement terminated in connection with the XTI Merger closing. Scott Pomeroy, the Company's CEO and Chairman, who was the CFO and board member of Legacy XTI up until the XTI Merger closing, provided consulting services to the Company during the nine months ended September 30, 2024 and 2023. Amounts paid to Mr. Pomeroy were not significant. As of September 30, 2024 and December 31, 2023, the Company owed Mr. Pomeroy accrued consulting compensation of $0.1 million, which is included in Related Party Payables within the accompanying condensed consolidated balance sheets. In addition and as disclosed in Note 12, Mr. Pomeroy was issued shares of Legacy XTI as transaction compensation immediately prior to the XTI Merger. Transactions with AVX Aircraft Company On March 25, 2024, the Company entered into a letter agreement, as amended on June 17, 2024, with AVX Aircraft Company ("AVX") whereas AVX is to provide consulting and advisory services relating to the development and design of the TriFan 600 aircraft. The Company's Chairman and CEO, Scott Pomeroy, and board member, David Brody, also sit on the Board of AVX. Additionally, as of the date of this report, David Brody owns approximately 26% of the issued and outstanding shares of AVX. During the three and nine months ended September 30, 2024, the Company paid AVX $0.8 million and $0.9 million in consulting fees, respectively, which included advance deposits for future services. As of September 30, 2024, the deposit balance for future services was approximately $0.5 million, and is included in prepaid expenses and other current assets on the accompanying condensed consolidated balance sheets. Agreements with Prior "Legacy Inpixon" CEO On March 12, 2024, the Company entered into a consulting agreement with Mr. Nadir Ali (the “Ali Consulting Agreement”), the Company's former Chief Executive Officer. Mr. Ali, through a company of which he is a controlling member, currently holds shares of the Company's Series 9 Preferred Stock as disclosed in Note 11. Pursuant to the Ali Consulting Agreement, following the closing of the XTI Merger, Mr. Ali will provide consulting services to the Company for 15 months ("Ali Consulting Period") or until earlier termination in accordance with its terms. During the Ali Consulting Period, the Company will pay him an aggregate of $0.3 million. In addition, the Company shall pay Mr. Ali (a) the amount of $1.5 million due three months following the Closing, and (b) the aggregate amount of $4.5 million, payable in 12 equal monthly installments, starting four months after the closing date of the XTI Merger (the payments described in (a) and (b), each an “Equity Payment”). Each Equity Payment may be made, in Company’s discretion, in (i) cash, (ii) fully vested shares of common stock under the Company’s equity incentive plan, or a combination of cash and registered shares. As of the date of this report, the Company repaid the initial $1.5 million owed to Mr. Ali under the Ali Consulting Agreement. During the three and nine months ended September 30, 2024, the Company recognized compensation expense of $1.0 million and $2.6 million, respectively, which is included in general and administrative expenses on the condensed consolidated statements of operations, relating to the Ali Consulting Agreement. As of September 30, 2024, the Company owed Mr. Ali accrued consulting fees of approximately $1.0 million, which is included in accounts payable on the accompanying condensed consolidated balance sheets. On July 24, 2023, the compensation committee of the Board (the “Compensation Committee”) adopted a Transaction Bonus Plan, which was amended on March 11, 2024, and was intended to provide incentives to certain employees, including Mr. Ali, and other service providers to remain with the Company through the consummation of a qualifying transaction. As of September 30, 2024, the Company had an transaction bonus obligation of approximately $2.7 million payable to Mr. Ali, which is included in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. Grafiti Group Divesiture On February 21, 2024, Inpixon completed the disposition of the remaining portion of the Shoom, SAVES, and GYG business lines and assets ("Grafiti Group Divestiture") in accordance with the terms and conditions of an Equity Purchase Agreement, dated February 16, 2024, by and among Inpixon (“Seller”), Grafiti LLC, and Grafiti Group LLC (an entity controlled by Nadir Ali, the Company's former CEO) (“Buyer”). Pursuant to the terms, Buyer acquired from 100% of the equity interest in Grafiti LLC, including the assets and liabilities primarily relating to Inpixon’s Saves, Shoom and Game Your Game business, including 100% of the equity interests of Inpixon India, Grafiti GmbH (previously Inpixon Gmbh) and Game Your Game, Inc. from the Company for a minimum purchase price of $1.0 million paid in two annual cash installments of $0.5 million due within 60 days after December 31, 2024 and 2025. The purchase price and annual cash installment payments will be (i) increased for 50% of net income after taxes, if any, from the operations of Grafiti LLC for the years ended December 31, 2024 and 2025; (ii) decreased for the amount of transaction expenses assumed; (iii) increased or decreased by the amount working capital of Grafiti LLC on the closing balance sheet is greater or less than $1.0 million. The Company notes that $0.5 million of the receivable is included in current assets as other receivables in the Company's condensed consolidated balance sheet as of September 30, 2024, and the remaining $0.5 million of the receivable is included in long term assets as other assets in the Company's condensed consolidated balance sheet as of September 30, 2024.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation From time to time, the Company is subject to various claims, charges and litigation matters that arise in the ordinary course of business. The Company records a provision for a liability when it is both probable that the loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, it discloses the possible loss or range of loss. Any potential gains associated with legal matters are not recorded until the period in which all contingencies are resolved and the gain is realized or realizable. Depending on the nature and timing of any such proceedings that may arise, an unfavorable resolution of a matter could materially affect the Company’s future consolidated results of operations, cash flows or financial position in a particular period. Except if otherwise indicated, it is not reasonably possible to determine the probability of loss or estimate damages for any of the matters discussed below, and therefore, the Company has not established reserves for any of these matters. On December 6, 2023, Xeriant filed a complaint against Legacy XTI, along with two unnamed companies and five unnamed persons, in the United States District Court for the Southern District of New York (the "Xeriant Matter"). On January 31, 2024, Xeriant filed an amended complaint, which added the Company as a defendant to the Xeriant Matter. On February 29, 2024, Xeriant filed a second amended complaint. The Xeriant Matter alleges that Legacy XTI has prevented Xeriant from obtaining compensation owed under various agreements entered into between Xeriant and Legacy XTI, including but not limited to a joint venture agreement, a cross-patent license agreement, an operating agreement, and a letter dated May 17, 2022 (the “May 17 letter”). In particular, Xeriant contends that Legacy XTI gained substantial advantages from the intellectual property, expertise, and capital deployed by Xeriant in the design and development of Legacy XTI’s TriFan 600 aircraft yet has excluded Xeriant from the transaction involving the TriFan 600 technology in its merger with Legacy Inpixon, which has resulted in a breach of the May 17 letter. Xeriant seeks damages in excess of $500 million, injunctive relief enjoining us from engaging in any further misconduct, the imposition of a royalty obligation, and such other relief as deemed appropriate by the court. On March 13, 2024, Legacy XTI moved for partial dismissal of the Xeriant Matter. The case is in its early stages, no discovery with respect to the Company has occurred. The Court has not scheduled hearings for Legacy XTI’s motion nor otherwise ruled upon it. Legacy XTI nevertheless denies the allegations of wrongdoing contained in the second amended complaint and is vigorously defending against the lawsuit. In connection with the Xeriant Matter, on June 12, 2024, we received a letter from counsel for Auctus Fund, LLC (“Auctus”), dated April 3, 2024, claiming that, pursuant to the above-referenced May 17 letter by and between Xeriant and Legacy XTI, as a result of the XTI Merger and Legacy XTI’s entry into a promissory note agreement with Legacy Inpixon in March 2023, XTI Aerospace and Legacy XTI may have assumed Xeriant’s obligations under that certain Senior Secured Promissory Note in the principal amount of $6,050,000 issued by Xeriant to Auctus, including the obligation to repay Auctus all principal and accrued and unpaid interest thereunder, which Auctus claims was $8,435,008.81 as of April 3, 2024. In July 2024, Legacy XTI responded to such letter and indicated that it believes that the May 17 letter is invalid and unenforceable on several bases. It further explained that even if it were valid and enforceable, Legacy XTI does not believe such letter resulted in, or otherwise triggered, the assumption of obligations of Xeriant under the Senior Secured Promissory Note or any other obligation on the part of Legacy XTI. There have been no further developments on this matter. We are unable to make a reasonable estimate of a potential loss, if any, on this matter. To the extent suits or actions are commenced with respect to this matter, we intend to vigorously defend against any and all claims. On or about August 1, 2024, Chardan Capital Markets LLC (”Chardan”) commenced an arbitration (the “Arbitration”) before FINRA against the Company and its subsidiary, XTI Aircraft Company (“Aircraft”). Aircraft and Chardan are parties to an engagement letter agreement (the “Agreement”). In the Arbitration, Chardan alleges that the Company is bound by the Agreement even though it did not sign the Agreement, which the Company denies. Chardan further alleges that Aircraft and the Company breached the Agreement by not making separate payments to Chardan of $200,000, $94,511, $484,044 and $174,000. Chardan also seeks to recover unspecified amounts relating to an alleged right of first refusal to perform banking services that the Company supposedly did not honor, including with respect to an At-The-Market securities offering that was underwritten by The Maxim Group LLC. The Company and Aircraft deny that Chardan performed its duties under the Agreement and otherwise that Chardan is owed any sums under the Agreement. The Company has filed a petition in the U.S. District Court for the Southern District of New York seeking to stay the Arbitration to the extent that it has been asserted against the Company. The Company has indicated that it plans to prosecute the foregoing Petition and, if the Arbitration is not stayed, defend against the Arbitration vigorously. As of September 30, 2024, the Company has accrued $200,000 relating to the Agreement, which is included in accounts payable on the condensed consolidated balance sheets. Financial Advisory Fees Pursuant to the terms of an amended advisory fees agreement between the Company and Maxim Group ("Maxim"), the Company is obligated to pay Maxim $0.2 million which becomes payable upon the closing of one or more debt or equity financings for which Maxim serves as placement agent or underwriter and in which the Company raises minimum aggregate gross proceeds of $10 million. Legacy XTI Deferred Compensation and Retention Bonus Plan In an effort to conserve cash, Legacy XTI implemented a cost savings plan, effective on July 1, 2022. As part of the cost savings plan, Legacy XTI installed a compensation reduction directive and retention bonus program impacting all employees and several current consultants. Accrued deferred compensation amounts under the cost savings plan will be repaid to participating individuals when executive management, at its sole discretion, determines that sufficient funding has been received by the Company, provided, in the case of employees, that such employees remain employed with the Company on such date. As part of the plan, Legacy XTI granted participants a retention bonus, of either cash or equity, at the participant’s discretion, equal in value to three months of their monthly deferred compensation amount, if cash, or six months of their monthly deferred compensation amount, if equity, if the employee remains with the Company at the “earn date,” which is defined as six months after the date on which the deferred compensation described above is repaid. Upon receiving additional financing during the first quarter of 2023, Legacy XTI restored the salaries of all employees to the original salary amount, effective with the semi-monthly payroll ended March 31, 2023. As of September 30, 2024, liability amounts of approximatel y $0.4 million and $0.1 million are included in accrued expenses and other current liabilities and related party payables, respectively, on the accompanying condensed consolidated balance sheets relating to deferred compensation and retention bonuses under this plan. Consulting Arrangement with Prior "Legacy Inpixon" CFO On March 12, 2024, the Company also entered into a Consulting Agreement with Ms. Wendy Loundermon (the “Loundermon Consulting Agreement”), the Company's former Chief Financial Officer. Pursuant to the Loundermon Consulting Agreement, following the Closing, Ms. Loundermon will provide consulting services to the Company for one year or until earlier termination in accordance with its terms (the “Loundermon Consulting Period”). As compensation for Ms. Loundermon’s consulting services, the Company will pay her (i) $83,333 per month for the first six months of the Loundermon Consulting Period for services she performs on an as-needed basis during the Loundermon Consulting Period regarding the transition of the management of the Company’s financial reporting function to ensure continuity of business operations, and (ii) $300 per hour for services performed on an as needed basis regarding the preparation and filing of Company’s public company financial reporting and compliance matters including accounting, payroll, audit and tax compliance functions. During the three and nine months ended September 30, 2024, the Company recognized compensation expense of $211,063 and $577,880, respectively, which is included in general and administrative expenses on the condensed consolidated statements of operations, relating to Ms. Loundermon's consulting arrangement. As of September 30, 2024, the Company owed Ms. Loundermon accrued consulting fees of $522,619, which is included in accounts payable and accrued expenses within the accompanying condensed consolidated balance sheets. Transaction Bonus Plan On July 24, 2023, the compensation committee of the Board (the “Compensation Committee”) adopted a Transaction Bonus Plan, which was amended on March 11, 2024, and was intended to provide incentives to certain employees and other service providers to remain with the Company through the consummation of a qualifying transaction. During the second quarter of 2024, the Company accrued 100% or $6.7 million of the transaction bonuses, which is included in general and administrative within the accompanying condensed consolidated statements of operations, as the bonuses became payable upon the earlier of the closing of financing or June 30, 2024. As of September 30, 2024, the Company had an aggregate accrued transaction bonus obligation of 5.5 million, which is included in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted loss per share attributable to common stockholders (in thousands, except share and per share data): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Net Loss $ (4,435) $ (2,703) $ (21,747) $ (8,897) Less: Preferred stock return and dividend (185) — (496) — Less: Deemed dividend (54) — (514) — Net Loss Attributable to Common Stockholders, basic and diluted $ (4,674) $ (2,703) $ (22,757) $ (8,897) Net Loss Per Share - Basic and Diluted $ (0.13) $ (0.66) $ (1.23) $ (2.26) Weighted Average Shares Outstanding, Basic and Diluted 34,986,105 4,116,700 18,439,744 3,931,075 The basic earnings per share calculation for the three months ended September 30, 2024 and 2023 included 209,688 and 608,528 penny warrant shares, respectively, since the exercise price was $0.01 per share. The basic earnings per share calculation for the nine months ended September 30, 2024 and 2023 included 608,528 and 608,528 of penny warrants shares, respectively. Additionally, the basic earnings per share calculation for the three months ended September 30, 2023 and for the nine months ended September 30, 2024 and 2023 included 298,395 shares of common stock that were issuable to Xeriant Inc. ("Xeriant") related to the joint venture arrangement that expired by its term on May 31, 2023. The shares were issued to Xeriant for no additional consideration immediately prior to the XTI Merger. The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Options 12,818,530 1,161,688 5,791,342 1,095,195 Warrants 278,963 163,603 457,094 142,276 Convertible preferred stock 2 — 2 — Convertible notes — 679,828 345,695 650,027 Total 13,097,495 2,005,119 6,594,133 1,887,498

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Subsequent to September 30, 2024 and through the date of this report, the Company entered into exchange agreements with the holder of shares of the Company’s Series 9 Preferred Stock pursuant to which the Company and the holder exchanged an aggregate 1,725 shares of Series 9 Preferred Stock with an aggregate stated value of approximately $1.8 million for an aggregate 25,071,318 shares of common stock at an effective price per share ranging between $0.05 and $0.19. Subsequent to September 30, 2024 and through the date of this report, the Company issued an aggregate 88,509,614 shares of common stock in connection with the ATM Offering at per share prices between approximately $0.06 and $0.19 , resulting in aggregate net proceeds to the Company of approximately $6.5 million. On July 9, 2024, the Company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days beginning on May 23, 2024, and ending on July 8, 2024, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided a period of 180 calendar days, or until January 6, 2025, in which to regain compliance with the minimum bid price requirement. On November 7, 2024, the Company received another letter (the "Low Price Deficiency Letter") from Nasdaq notifying the Company that, as of November 6, 2024, the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule"). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Capital Market (the "Determination"), unless the Company requests an appeal of the Determination on or prior to November 14, 2024, pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. The Company requested a hearing before the Nasdaq Hearings Panel (the "Panel") to appeal the Determination and to address compliance with the Low Priced Stocks Rule. The Low Price Deficiency Letter states that hearings are typically scheduled to occur approximately 30-45 days after the date of the hearing request. The Company will be asked to provide the Panel with a plan to regain compliance, which plan the Company is in the process of preparing. The Low Price Deficiency Letter has no immediate effect on the listing of the Company’s common stock on Nasdaq and its common stock will continue to be listed on the Nasdaq Capital Market under the symbol "XTIA." While the appeal process is pending, the suspension of trading of the Company’s common stock would be stayed and the Company’s common stock would continue to trade on The Nasdaq Capital Market until the hearing process concludes and the Panel issues a written decision. There can be no assurance, however, that the Company will be successful in its appeal to the Panel or be able to regain or maintain compliance with the Nasdaq listing rules.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Loss	$ (4,435)	$ (14,710)	$ (2,602)	$ (2,703)	$ (4,629)	$ (1,565)	$ (21,747)	$ (8,897)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Consolidations	Consolidations The consolidated financial statements have been prepared using the accounting records of Legacy XTI and as of March 12, 2024 and forward (the effective date of the XTI Merger) the accounting records of XTI Aerospace, Inc. (formerly known as Inpixon), Inpixon GmbH (formerly known as Nanotron Technologies GmbH), Inpixon Holding UK Limited, and Intranav GmbH. All material inter-company balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of: • the valuation of stock-based compensation; • the valuation of the Company’s common stock issued and assets acquired in transactions, including acquisitions; • the valuation of equity securities; • the valuation of notes receivable; • the valuation of warrant liabilities and assets; • the valuation of convertible notes, at fair value; • the valuation of loan conversion derivatives; and • the valuation allowance for deferred tax assets.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash consists primarily of demand deposit bank accounts, which, from time to time, may exceed federally insured limits. The Company considers all highly liquid investments with an original maturity from date of purchase of three months or less, or that are readily convertible into known amounts of cash, to be cash equivalents.
Credit Risk and Concentrations	Credit Risk and Concentrations Financial instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk. The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk of its customers, establishes an allowance for credit losses.
Business Combinations	Business Combinations
Acquired In-Process Research and Development (“IPR&D”)	Acquired In-Process Research and Development (“IPR&D”)
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible assets primarily consist of developed technology, patents, customer relationships, and trade names/trademarks. They are amortized ratably over a range of 5 to 15 years, which approximates customer attrition rate and technology obsolescence. The Company tests goodwill for potential impairment at least annually as of October 1, or more frequently if events or changes in circumstances indicate that the asset may be impaired . Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying amount and the Company recognizes an impairment charge, if any, for the amount by which the carrying amount exceeds the reporting unit’s fair value.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company reviews its long-lived assets, inclusive of its right-of-use assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated from the use of the asset and its eventual disposition. If the carrying amount of an asset group exceeds its estimated future undiscounted cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset group exceeds its fair value.
Revenue Recognition	Revenue Recognition In accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer. Hardware and Software Revenue Recognition For sales of hardware and software products, the Company’s performance obligation is satisfied at a point in time when they are shipped to the customer, at which control is deemed transferred to the customer, and has title of the product and holds the risks and rewards of ownership. The Company leverages drop-ship arrangements with many of its vendors and suppliers to deliver products to customers without having to physically hold the inventory at its warehouse. In such arrangements, the Company negotiates the sale price with the customer, pays the supplier directly for the product shipped, bears credit risk of collecting payment from its customers and is ultimately responsible for the acceptability of the product and ensuring that such product meets the standards and requirements of the customer. Accordingly, the Company concluded it is the principal in the transaction with the customer and records revenue on a gross basis. The Company receives fixed consideration for sales of hardware and software products. The Company’s customers generally pay within 30 to 60 days from the receipt of a customer approved invoice. The Company has elected the practical expedient to expense the costs of obtaining a contract when they are incurred because the amortization period of the asset that otherwise would have been recognized is less than a year. Software As A Service Revenue Recognition With respect to sales of the Company’s maintenance, consulting and other service agreements, customers pay fixed monthly fees in exchange for the Company’s service. The Company’s performance obligation is satisfied over time as the digital advertising and electronic services are provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous access to its service. Professional Services Revenue Recognition The Company’s professional services include milestone, fixed fee and time and materials contracts. Professional services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract can be estimated reliably, contract revenue is recognized in the consolidated statement of operations in proportion to the stage of completion of the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract, are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract. Professional services are also contracted on the fixed fee and time and materials basis. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company’s time and materials contracts are paid weekly or monthly based on hours worked. Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date. For fixed fee contracts including maintenance service provided by in house personnel, the Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous service. Because the Company’s contracts have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the nine months ended September 30, 2024 and 2023, the Company did not incur any such losses. These amounts are based on known and estimated factors. License Revenue Recognition The Company enters into contracts with its customers whereby it grants a non-exclusive on-premise license for the use of its proprietary software. The contracts provide for a stated term with a one year or multiple year renewal option. The contracts may also provide for yearly on-going maintenance services for a specified price, which includes maintenance services, designated support, and enhancements, upgrades and improvements to the software (the “Maintenance Services”), depending on the contract. Licenses for on-premises software provide the customer with a right to use the software as it exists when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over which the customer benefits from the software. The timing of the Company's revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement entered into represents a good or service. Software that relies on an entity’s IP and is delivered only through a hosting arrangement, where the customer cannot take possession of the software, is a service. A software arrangement that is provided through an access code or key represents the transfer of a good. Licenses for on-premises software represents a good and provide the customer with a right to use the software as it exists when made available to the customer. Customers may purchase perpetual licenses or subscribe to licenses, which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software. Revenue from distinct on-premises licenses is recognized upfront at the point in time when the software is made available to the customer. Renewals or extensions of licenses are evaluated as distinct licenses (i.e., a distinct good or service), and revenue attributed to the distinct good or service cannot be recognized until (1) the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. Therefore, the Company recognizes revenue resulting from renewal of licensed software at a point in time, specifically, at the beginning of the license renewal period. The Company recognizes revenue related to Maintenance Services evenly over the service period using a time-based measure because the Company is providing continuous service and the customer simultaneously receives and consumes the benefits provided by the Company’s performance as the services are performed. Contract Balances The timing of the Company’s revenue recognition may differ from the timing of payment by its customers. The Company records a receivable when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied, principally within one year. Customer Deposits The Company periodically enters into aircraft reservation agreements that include a deposit placed by a potential customer. The deposits serve to prioritize orders when the aircraft becomes available for delivery. Customers making deposits are not obligated to purchase aircraft until they execute a definitive purchase agreement. Customers may request return of their deposit any time up until the execution of a purchase agreement. The Company records such advance deposits as a liability and defers the related revenue recognition until delivery of an aircraft occurs, if any. Disaggregation of Revenue
Stock-Based Compensation	Stock-Based Compensation The Company’s stock-based compensation relates to stock options granted to employees and non-employees. The Company recognizes the cost of share-based awards granted to employees and non-employees based on the estimated grant-date fair value of the awards. Forfeitures are accounted for as they occur, which may result in negative expense when forfeitures exceed the expense recorded within the period. The Company recognizes expense on a straight-line basis over the requisite service period of the award, which is generally equal to the vesting period of the award. The Company estimates the grant-date fair value of the stock option awards with service only vesting conditions using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model utilizes inputs and assumptions which involve inherent uncertainties and generally require significant judgment. As a result, if factors or expected outcomes change and significantly different assumptions or estimates are used, the Company’s stock-based compensation could be materially different. Significant inputs and assumptions include: Fair value of Common Stock – As there was no public market for Legacy XTI’s common stock prior to the XTI Merger, the fair value of the shares of common stock underlying the stock-based awards on the grant-date has historically been determined by Legacy XTI’s Board of Directors with assistance of third-party valuation specialists. Legacy XTI's Board of Directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair market value, which included important developments in Legacy XTI’s operations, actual operating results, financial performance, external market conditions, equity market conditions of comparable public companies, and the lack of marketability of Legacy XTI’s common stock. Expected Term – The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term). Expected Volatility – Because Legacy XTI was privately held prior to the XTI Merger and did not have an active trading market for its common stock, the expected volatility was estimated based on the average volatility for publicly traded companies that the Company considers to be comparable, over a period equal to the expected term of the stock option grants. Risk-Free Interest Rate – The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of option. Expected Dividend – The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.
Net Loss Per Share	Net Loss Per Share Net loss per share attributable to common stockholders is computed using the two-class method required for multiple classes of common stock and participating securities. The Company’s participating securities included the Company’s convertible preferred stock and preferred stock. Neither the holders of convertible preferred stock, preferred stock nor the holders of the Company’s common stock warrants have a contractual obligation to share in losses. Basic net loss per share attributable to common stockholders is calculated by dividing the net loss, as adjusted for any dividends on the preferred stock for the period, attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, adjusted for outstanding shares that are subject to repurchase or outstanding shares that are contingently returnable by the holder. Contingently issuable shares, including shares that are issuable for little or no cash consideration, are considered outstanding common shares and included in net loss per share as of the date that all necessary conditions have been satisfied. Such shares include outstanding penny warrants and shares issuable to Xeriant Inc. ("Xeriant") related to the the joint venture arrangement that expired on May 31, 2023. Diluted net loss per share is computed by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. For periods in which the Company reports net losses, diluted net loss per common share attributable to common stockholders is the same as basic net loss per common share attributable to common stockholders, because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.
Segments	Segments The Company and its Chief Executive Officer ("CEO"), acting as the Chief Operating Decision Maker ("CODM") determined its operating segments in accordance with ASC 280, "Segment Reporting" ("ASC 280"). The Company is organized and operates as two business segments based on similar economic characteristics, the nature of products and production processes, end-use markets, channels of distribution, and regulatory environments.
Recently Issued and Adopted Accounting Standards / Recently Issued Accounting Standards Not Yet Adopted	Recently Issued and Adopted Accounting Standards In July 2023, the FASB issued ASU 2023-03, "Presentation of Financial Statements (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718)", which updates codification on how an entity would apply the scope guidance in paragraph 718-10-15-3 to determine whether profits interest and similar awards should be accounted for in accordance with Topic 718, Compensation—Stock Compensation. The effective date of this update is for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2023-03 as of January 1, 2024. The adoption of this guidance did not have a material impact on the condensed consolidated financial statements and disclosures. Recently Issued Accounting Standards Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the chief operating decision maker. The standard is effective for the Company beginning in fiscal year 2024 and interim periods within fiscal year 2025, with early adoption permitted. The Company does not expect to early adopt the new standard. The Company is currently evaluating the impact of ASU 2023-07 on its financial statements and related disclosures. In December 2023, the FASB also issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for the Company for annual periods beginning after December 15, 2024, with early adoption permitted. The Company does not expect to early adopt the new standard. The new standard is expected to be applied prospectively, but retrospective application is permitted. The Company is currently evaluating the impact of ASU 2023-09 on its financial statements and related disclosures.
Fair Value of Financial Instruments and Fair Value Measurements	The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Schedules of Concentration of Risk, by Risk Factor	The customers who account for 10% or more of the Company's revenue for the three and nine months ended September 30, 2024 or 10% or more of the Company's outstanding receivable balance as of September 30, 2024 are presented as follows: Percentage of revenues Percentage of accounts receivable Customer For the Three Months Ended September 30, 2024 For the Nine Months Ended September 30, 2024 As of September 30, 2024 A 25% 23% ** B ** 17% ** C 25% 16% 29% D 13% 12% 10% E ** ** 10% F ** ** 24% **Represents less than 10% of the total for the respective period The Company did not have revenue for the three and nine months ended September 30, 2023. The Company did not have outstanding trade receivables as of September 30, 2023. The vendors who account for 10% or more of the Company's purchases or 10% or more of the Company's outstanding payable balance are presented as follows for the periods indicated: Percentage of purchases Percentage of accounts payable Three Months Ended September 30, Nine Months Ended September 30, As of September 30, Vendor 2024 2023 2024 2023 2024 2023 A ** 45% ** 42% 21% 61% B ** ** ** 11% ** ** C ** ** ** ** ** 23% **Represents less than 10% of the total for the respective period

Disaggregation of Revenue and_2

Disaggregation of Revenue and Deferred Revenue (Tables)	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Revenues consisted of the following (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Recurring revenue Software $ 327 $ — $ 697 $ — Total recurring revenue $ 327 $ — $ 697 $ — Non-recurring revenue Hardware $ 422 $ — $ 1,190 $ — Software 77 — 82 — Professional services 92 — 200 — Total non-recurring revenue $ 591 $ — $ 1,472 $ — Total Revenue $ 918 $ — $ 2,169 $ — For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenue recognized at a point in time Industrial IoT (1) $ 499 $ — $ 1,272 $ — Total $ 499 $ — $ 1,272 $ — Revenue recognized over time Industrial IoT (2) (3) $ 419 $ — $ 897 $ — Total $ 419 $ — $ 897 $ — Total Revenue $ 918 $ — $ 2,169 $ — (1) Hardware and Software's performance obligation is satisfied at a point in time when they are shipped to the customer. (2) Professional services are also contracted on the fixed fee and time and materials basis. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date, in which revenue is recognized over time. (3) Software As A Service Revenue's performance obligation is satisfied evenly over the service period using a time-based measure because the Company is providing continuous access to its service and revenue is recognized over time.

Merger Transaction (Tables)

Merger Transaction (Tables)	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Business Acquisitions	The below summarizes the total consideration transferred in the business combination (in thousands): Fair value of common stock $ 10,939 Fair value of warrants 3,250 Fair value of preferred stock 11,302 Fair value of debt assumed 114 Total consideration $ 25,605
Schedule of Warrants	Significant inputs related to these warrants are as follows: Fair value of common stock $ 5.27 Exercise price $ 5.13 Expected term 4.76 years Volatility 146 % Risk-free interest rate 4.2 % Dividend yield — % The following table summarizes the activity of warrants outstanding: Number of Warrants Beginning balance as of January 1, 2024 771,895 Legacy Inpixon warrants from merger 1,448,481 Granted 167,664 Exercised (409,815) Expired (96,659) Exchanged (1,602,630) Ending balance as of September 30, 2024 278,936 Exercisable as of September 30, 2024 89,780
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the preliminary purchase price allocations relating to the XTI Merger (in thousands): Assets acquired Cash and cash equivalents $ 2,968 Accounts receivable 696 Notes and other receivables 7,929 Inventory 3,283 Prepaid assets and other current assets 756 Property and equipment 246 Other assets 1,202 Warrant assets 448 Tradename & trademarks 913 Proprietary technology 2,934 Customer relationships 702 In process research and development 243 Goodwill 12,398 34,718 Liabilities assumed Accounts payable 2,675 Accrued liabilities 4,282 Operating lease obligation 299 Deferred revenue 824 Short-term debt 114 Warrant liability 919 Total liabilities assumed 9,113 Estimated fair value of assets acquired $ 25,605

Proforma Financial Information

Proforma Financial Information (Tables)	9 Months Ended
	Sep. 30, 2024
Business Acquisition, Pro Forma Information [Abstract]
Schedule of Pro Forma Information	The proforma financial information for the Company and Legacy Inpixon is as follows (in thousands): For the Three Months Ended September 30, 2024 For the Three Months Ended September 30, 2023 Revenues $ 918 $ 759 Net loss attributable to common stockholders $ (4,674) $ (9,944) Net loss per basic and diluted share $ (0.13) $ (1.17) Weighted average common shares outstanding: Basic and Diluted 34,986,105 8,476,635 The proforma financial information for the Company and Legacy Inpixon is as follows (in thousands): For the Nine Months Ended September 30, 2024 For the Nine Months Ended September 30, 2023 Revenues $ 2,676 $ 3,486 Net loss attributable to common stockholders $ (36,571) $ (28,397) Net loss per basic and diluted share $ (1.83) $ (3.35) Weighted average common shares outstanding: Basic and Diluted 20,006,531 8,475,135

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the changes in the carrying amount of Goodwill for the nine months ended September 30, 2024 (in thousands): Amount Beginning balance - January 1, 2024 $ — Goodwill recognized in connection with XTI Merger - Note 5 12,398 Foreign currency translation adjustment 340 Ending balance - September 30, 2024 $ 12,738
Schedule of Finite-Lived Intangible Assets	Intangible assets at September 30, 2024 and December 31, 2023 consisted of the following (in thousands): September 30, 2024 Gross Amount Accumulated Amortization Net Carrying Amount Remaining Weighted Average Useful Life Patents $ 452 $ (176) $ 276 9.7 Trade Name/Trademarks 945 (103) 842 4.5 Proprietary Technology 3,012 (237) 2,775 6.5 Customer Relationships 721 (79) 642 4.5 In-Process R&D 243 — 243 3.0 Total $ 5,373 $ (595) $ 4,778 December 31, 2023 Gross Amount Accumulated Amortization Net Carrying Amount Patents $ 413 $ (155) $ 258 Trade Name/Trademarks 8 — 8 Total $ 421 $ (155) $ 266
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Future amortization expense on intangibles assets is anticipated to be as follows (in thousands): Amount December 31, 2024 (for 3 months) $ 198 December 31, 2025 873 December 31, 2026 873 December 31, 2027 873 December 31, 2028 792 December 31, 2029 and thereafter 1,169 Total $ 4,778

Other Balance Sheet Informati_2

Other Balance Sheet Information (Tables)	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): As of September 30, 2024 As of December 31, 2023 AVX deposit - related party $ 523 $ — Prepaid insurance 460 13 Other 340 — Fulfillment costs 286 — Prepaid software 95 90 Deposits — 22 Total prepaid expenses and other current assets $ 1,704 $ 125
Schedule of Inventory	Inventory as of September 30, 2024 consisted of the following (in thousands): As of September 30, 2024 Raw materials $ 33 Work-in-process 125 Finished goods 2,572 Total inventory $ 2,730
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities liabilities as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands): As of September 30, 2024 As of December 31, 2023 Accrued transaction bonuses $ 5,782 $ — Accrued compensation and benefits 1,120 649 Accrued bonus and commissions 1,196 305 Accrued other 561 173 Total accrued expenses and other current liabilities $ 8,659 $ 1,127

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Debt	The Company's outstanding debt consisted of the following at the periods indicated (in thousands): Short-Term Debt Maturity September 30, 2024 December 31, 2023 Promissory Note - 2023 $ — $ 3,071 Promissory Note - 2023 - related party — 125 Convertible Note - 2021 - related party 1 — 1,079 Convertible Note - 2021 1 — 2,500 Promissory Note - May 1, 2024 5/1/2025 1,419 — Promissory Note - May 24, 2024 5/24/2025 1,386 — Third Party Note Payable - 2023 12/31/2024 42 — Third Party Note Payable - 2024 12/14/2024 129 — Unamortized Discounts (356) (50) Unamortized Loan Costs — (35) Total Short-Term Debt $ 2,620 $ 6,690 Long-Term Debt SBA loan 6/3/2050 $ 65 $ 65 Convertible notes, at fair value 1 — 16,804 Convertible Note - 2017 1 — 1,987 Convertible Note - 2022 1 — 600 Convertible Note - 2023 1 — 300 Unamortized Discounts — (1,210) Total Long-Term Debt $ 65 $ 18,546 1 principal balance was either converted to equity immediately prior to the XTI Merger closing time or subsequently repaid

Common Stock (Tables)

Common Stock (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Debt Conversions	The Company accounted for these conversions as an inducement and recognized a loss related to the fair value of the additional shares issued compared to the original terms of the convertible note, which is included in inducement loss on debt conversions in the other income and expense section of the condensed consolidated statement of operations. The following table details the notes converted into shares of Legacy XTI common stock (in thousands, except conversion price). Letter Agreement Aggregate Principal and Interest Outstanding Immediately Prior to XTI Merger Aggregate Principal and Interest Converted to Common Shares Reduced Conversion Price Post - Exchange Ratio Common Shares Outstanding Payment Obligation Immediately After XTI Merger Net Inducement Charge Convertible Note 2021 $ 2,777 $ 2,504 $ 0.265 844 $ 273 $ 3,266 Convertible Note 2017 $ 2,148 $ 2,148 $ 0.265 724 $ — $ 2,795 Convertible Note 2022 $ 682 $ 600 $ 0.265 202 $ 82 $ 464 Convertible Note 2023 $ 333 $ 300 $ 0.265 101 $ 33 $ 207 Totals $ 5,940 $ 5,552 1,871 $ 388 $ 6,732

Stock Award Plans and Stock Bas

Stock Award Plans and Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options Roll Forward	See below for a summary of the stock options granted under the 2011, 2017, and 2018 plans: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Aggregate Intrinsic Value (In millions) Beginning balance as of January 1, 2024 1,161,687 $ 17.95 6.7 $ — Legacy Inpixon stock options from merger 1,148 61.67 Granted 12,565,606 0.47 Exercised (92,718) 0.00 Expired (242) 19,043.35 Forfeited (853,299) 8.83 Ending balance as of September 30, 2024 12,782,182 $ 1.87 9.6 $ — Options vested and exercisable as of September 30, 2024 852,174 15.13 7.6 — Grantee Grant Date Vesting Start Date Options Granted Chief Executive Officer of XTI Aerospace, Inc. 6/12/2024 6/12/2024 2,812,500 Chief Financial Officer of XTI Aerospace, Inc. 6/12/2024 6/12/2024 1,640,625 Chief Executive Officer of the XTI Aerospace, Inc. Real-Time Location System Division 6/12/2024 6/12/2024 975,000 Chief Strategy Officer of XTI Aerospace, Inc. 9/19/2024 8/1/2024 1,171,875 Total Granted 6,600,000
Schedule of Estimating the Fair Values of Options	The following assumptions were used in estimating the fair values of options awarded during the nine months ended September 30, 2024: Fair value of common stock $0.191 - $0.473 Exercise price $0.191 - $0.473 Expected term 10.0 years Volatility 95.06% - 96.17% Risk-free interest rate 3.58% - 4.32% Dividend yield — %
Schedule of Stock-based Compensation Charges	The Company incurred the following stock-based compensation charges for the periods indicated below (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Employee and consultant stock options 1 $ (2,159) $ 164 $ (2,075) $ 2,766 Professional fees 1 270 — 270 — Vesting of previously unvested warrants 2 — — 496 — Merger-related professional fees 2 — — 5,153 — Total $ (1,889) $ 164 $ 3,844 $ 2,766 1 amount included in general and administrative expenses on the condensed consolidated statements of operations 2 amount included in merger-related transaction costs on the condensed consolidated statements of operations

Warrants (Tables)

Warrants (Tables)	9 Months Ended
	Sep. 30, 2024
Warrants [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights	Significant inputs related to these warrants are as follows: Fair value of common stock $ 5.27 Exercise price $ 5.13 Expected term 4.76 years Volatility 146 % Risk-free interest rate 4.2 % Dividend yield — % The following table summarizes the activity of warrants outstanding: Number of Warrants Beginning balance as of January 1, 2024 771,895 Legacy Inpixon warrants from merger 1,448,481 Granted 167,664 Exercised (409,815) Expired (96,659) Exchanged (1,602,630) Ending balance as of September 30, 2024 278,936 Exercisable as of September 30, 2024 89,780

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Revenue by Major Customers and Reporting Segments	The following table reflects results of operations from our business segments for the periods indicated below (in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Revenue by Segment Industrial IoT $ 918 $ — $ 2,169 $ — Commercial Aviation — — — — Total segment revenue $ 918 $ — $ 2,169 $ — Gross profit by Segment Industrial IoT $ 520 $ — $ 1,323 $ — Commercial Aviation — — — — Gross profit by Segment $ 520 $ — $ 1,323 $ — Research and Development Expenses by Segment Industrial IoT $ 609 $ — 1,361 — Commercial Aviation 619 472 1,479 1,299 Research and Development Expenses by Segment $ 1,228 $ 472 $ 2,840 $ 1,299 Income (loss) from operations by Segment Industrial IoT $ (1,312) $ — $ (2,788) $ — Commercial Aviation 1,788 (2,378) (7,161) (7,702) Loss from operations by segment $ 476 $ (2,378) $ (9,949) $ (7,702) Unallocated costs (4,692) — (17,071) — Consolidated loss from operations $ (4,216) $ (2,378) $ (27,020) $ (7,702)
Schedule of Total Assets by Reportable Segment	The following table presents total assets by reportable segment (in thousands): September 30, December 31, 2024 2023 Industrial IoT $ 21,583 $ — Commercial Aviation 1,231 509 Total assets by segment $ 22,814 $ 509 Corporate 6,469 — Total consolidated assets $ 29,283 $ 509

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Assets	The Company's assets and liabilities measured at fair value consisted of the following at the periods indicated: Fair value at September 30, 2024 Total Level 1 Level 2 Level 3 Assets: Notes receivable $ 3,601 $ — $ — $ 3,601 Warrant asset 424 — — 424 Total assets 4,025 — — 4,025 Fair Value at December 31, 2023 Total Level 1 Level 2 Level 3 Liabilities: Warrant liability $ 497 $ — $ — $ 497 Convertible notes, at fair value 16,804 — — 16,804 Loan conversion derivatives 333 — — 333 Total liabilities 17,634 — — 17,634
Schedule of Reconciliation of Liabilities for Level 3 Investments	The table below provides a summary of changes in the estimated fair value of the Company's Level 3 assets and liabilities: Notes receivable Warrant asset Warrant liability Convertible notes, at fair value Loan conversion derivatives Balance at January 1, 2024 $ — $ — $ 497 $ 16,804 $ 333 Acquired 3,264 448 920 — — Change in fair value — — (398) (12,882) — Exchanged / Conversion to Equity — — — (3,922) (333) Balance at March 31, 2024 $ 3,264 $ 448 $ 1,019 $ — $ — Change in fair value 38 (24) 679 — — Accrued interest 91 — — — — Debt discount recognition 49 — — — — Exchanged / Conversion to Equity — — (1,698) — — Balance at June 30, 2024 $ 3,442 $ 424 $ — $ — $ — Change in fair value 20 — — — — Accrued interest 90 — — — — Debt discount recognition 49 — — — — Balance at September 30, 2024 $ 3,601 $ 424 $ — $ — $ —

Foreign Operations (Tables)

Foreign Operations (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Revenue from External Customers by Geographic Areas	The financial data by geographic area are as follows (in thousands): United Germany United Kingdom Eliminations Total For the Three Months Ended September 30, 2024: Revenues by geographic area $ 435 $ 622 $ — $ (139) $ 918 Operating (loss) income by geographic area $ (3,167) $ (1,049) $ — $ — $ (4,216) Net (loss) income by geographic area $ (3,389) $ (1,046) $ — $ — $ (4,435) For the Three Months Ended September 30, 2023: Revenues by geographic area $ — $ — $ — $ — $ — Operating (loss) income by geographic area $ (2,378) $ — $ — $ — $ (2,378) Net (loss) income by geographic area $ (2,703) $ — $ — $ — $ (2,703) For the Nine Months Ended September 30, 2024: Revenues by geographic area $ 758 $ 1,689 $ — $ (278) $ 2,169 Operating (loss) income by geographic area $ (25,146) $ (1,874) $ — $ — $ (27,020) Net (loss) income by geographic area $ (19,886) $ (1,861) $ — $ — $ (21,747) For the Nine Months Ended September 30, 2023: Revenues by geographic area $ — $ — $ — $ — $ — Operating (loss) income by geographic area $ (7,702) $ — $ — $ — $ (7,702) Net (loss) income by geographic area $ (8,897) $ — $ — $ — $ (8,897) As of September 30, 2024: Identifiable assets by geographic area $ 43,253 $ 23,322 $ 10 $ (37,302) $ 29,283 Long lived assets by geographic area $ 2,086 $ 3,449 $ — $ — $ 5,535 Goodwill by geographic area $ 3,142 $ 9,596 $ — $ — $ 12,738 As of December 31, 2023: Identifiable assets by geographic area $ 509 $ — $ — $ — $ 509 Long lived assets by geographic area $ 278 $ — $ — $ — $ 278 Goodwill by geographic area $ — $ — $ — $ — $ —

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents the calculation of basic and diluted loss per share attributable to common stockholders (in thousands, except share and per share data): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Net Loss $ (4,435) $ (2,703) $ (21,747) $ (8,897) Less: Preferred stock return and dividend (185) — (496) — Less: Deemed dividend (54) — (514) — Net Loss Attributable to Common Stockholders, basic and diluted $ (4,674) $ (2,703) $ (22,757) $ (8,897) Net Loss Per Share - Basic and Diluted $ (0.13) $ (0.66) $ (1.23) $ (2.26) Weighted Average Shares Outstanding, Basic and Diluted 34,986,105 4,116,700 18,439,744 3,931,075
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Options 12,818,530 1,161,688 5,791,342 1,095,195 Warrants 278,963 163,603 457,094 142,276 Convertible preferred stock 2 — 2 — Convertible notes — 679,828 345,695 650,027 Total 13,097,495 2,005,119 6,594,133 1,887,498

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended						9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2024 USD ($) segment $ / shares	Sep. 30, 2023 USD ($) $ / shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Working capital surplus (deficit)	$ (11,900,000)						$ (11,900,000)
Cash	500,000						500,000
Net loss	$ 4,435,000	$ 14,710,000	$ 2,602,000	$ 2,703,000	$ 4,629,000	$ 1,565,000	21,747,000	$ 8,897,000
Net cash used in operating activities							14,305,000	2,986,000
Long-lived assets impairment							$ 0	$ 0
Revenue from contract with customer, stated term							1 year
Exercise price of warrants (in usd per share) | $ / shares	$ 0.01			$ 0.01			$ 0.01	$ 0.01
Number of operating segments | segment							2
Minimum
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Intangible asset, useful life	5 years						5 years
Maximum
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Intangible asset, useful life	15 years						15 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedules of Concentration of Risk, by Risk Factor (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Purchases | Supplier Concentration Risk | Vendor A
Concentration Risk [Line Items]
Concentration risk percentage		45%		42%
Purchases | Supplier Concentration Risk | Vendor B
Concentration Risk [Line Items]
Concentration risk percentage				11%
Accounts Payable | Supplier Concentration Risk | Vendor A
Concentration Risk [Line Items]
Concentration risk percentage			21%	61%
Accounts Payable | Supplier Concentration Risk | Vendor C
Concentration Risk [Line Items]
Concentration risk percentage				23%
Customer A | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	25%		23%
Customer B | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			17%
Customer C | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	25%		16%
Customer C | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			29%
Customer D | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	13%		12%
Customer D | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			10%
Customer E | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			10%
Customer F | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage			24%

Disaggregation of Revenue and_3

Disaggregation of Revenue and Deferred Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total Revenue	$ 918	$ 0	$ 2,169	$ 0
Revenue recognized at a point in time
Disaggregation of Revenue [Line Items]
Total Revenue	499	0	1,272	0
Revenue recognized at a point in time | Industrial IoT
Disaggregation of Revenue [Line Items]
Total Revenue	499	0	1,272	0
Revenue recognized over time
Disaggregation of Revenue [Line Items]
Total Revenue	419	0	897	0
Revenue recognized over time | Industrial IoT
Disaggregation of Revenue [Line Items]
Total Revenue	419	0	897	0
Recurring revenue
Disaggregation of Revenue [Line Items]
Total Revenue	327	0	697	0
Non-recurring revenue
Disaggregation of Revenue [Line Items]
Total Revenue	591	0	1,472	0
Software | Recurring revenue
Disaggregation of Revenue [Line Items]
Total Revenue	327	0	697	0
Software | Non-recurring revenue
Disaggregation of Revenue [Line Items]
Total Revenue	77	0	82	0
Hardware | Non-recurring revenue
Disaggregation of Revenue [Line Items]
Total Revenue	422	0	1,190	0
Professional services | Non-recurring revenue
Disaggregation of Revenue [Line Items]
Total Revenue	$ 92	$ 0	$ 200	$ 0

Disaggregation of Revenue and_4

Disaggregation of Revenue and Deferred Revenue - Narrative (Details) - USD ($)	Sep. 30, 2024	Mar. 12, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Contract with customer, liability	$ 500,000		$ 0
Inpixon and Superfly Merger Sub Inc.
Disaggregation of Revenue [Line Items]
Deferred revenue		$ 824,000

Merger Transaction - Schedule o

Merger Transaction - Schedule of Business Acquisitions (Details) - Inpixon and Superfly Merger Sub Inc. - USD ($) $ in Thousands		2 Months Ended
	Mar. 12, 2024	Mar. 12, 2024
Business Acquisition [Line Items]
Fair value of debt assumed	$ 114
Total consideration	25,605
Common Stock
Business Acquisition [Line Items]
Shares issued in business combination	10,939
Warrants
Business Acquisition [Line Items]
Shares issued in business combination	3,250
Preferred Stock
Business Acquisition [Line Items]
Shares issued in business combination	$ 11,302	$ 11,300

Merger Transaction - Narrative

Merger Transaction - Narrative (Details)		2 Months Ended	3 Months Ended		9 Months Ended
	Mar. 12, 2024 USD ($) $ / shares	Mar. 12, 2024 USD ($) $ / shares	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($) $ / shares	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares
Business Acquisition [Line Items]
Common stock, par value (in usd per share) | $ / shares			$ 0.001		$ 0.001		$ 0.001
Warrant liability			$ 0		$ 0		$ 497,000
Exercise price of warrants (in usd per share) | $ / shares			$ 0.01	$ 0.01	$ 0.01	$ 0.01
Preferred stock, par value (in usd per share) | $ / shares			$ 0.001		$ 0.001		$ 0.001
Merger-related transaction costs			$ 0	$ 713,000	$ 6,490,000	$ 1,428,000
Inpixon and Superfly Merger Sub Inc.
Business Acquisition [Line Items]
Common stock, value, outstanding	$ 2,075,743	$ 2,075,743
Common stock, par value (in usd per share) | $ / shares	$ 5.27	$ 5.27
Stock split conversion ratio	0.01
Warrant liability	$ 918,689	$ 918,689
Exercise price of warrants (in usd per share) | $ / shares	$ 1	$ 1
Remainder of warrants and rights outstanding	$ 491,310	$ 491,310
Remainder of class of warrant or right, exercise price of warrants or rights (in usd per share) | $ / shares	$ 4.75	$ 4.75
Preferred stock, value, outstanding	$ 11,302	$ 11,302
Preferred stock, value, issued	$ 11,302	$ 11,302
Preferred stock, par value (in usd per share) | $ / shares	$ 1,000	$ 1,000
Tax deductible goodwill	$ 5,800,000	$ 5,800,000
Inpixon and Superfly Merger Sub Inc. | Warrants
Business Acquisition [Line Items]
Shares issued in business combination	3,250,000
Inpixon and Superfly Merger Sub Inc. | Series 9 Preferred Stock at Redemption Value
Business Acquisition [Line Items]
Shares issued in business combination	$ 11,302,000	$ 11,300,000

Merger Transaction - Schedule_2

Merger Transaction - Schedule of Warrants (Details) - Warrants - Inpixon and Superfly Merger Sub Inc.	Mar. 12, 2024 $ / shares
Business Acquisition [Line Items]
Fair value of common stock (in usd per share)	$ 5.27
Exercise price (in usd per share)	$ 5.13
Expected term	4 years 9 months 3 days
Volatility	146%
Risk-free interest rate	4.20%
Dividend yield	0%

Merger Transaction - Schedule_3

Merger Transaction - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Mar. 12, 2024	Dec. 31, 2023
Assets acquired
Goodwill	$ 12,738		$ 0
Inpixon and Superfly Merger Sub Inc.
Assets acquired
Cash and cash equivalents		$ 2,968
Accounts receivable		696
Notes and other receivables		7,929
Inventory		3,283
Prepaid assets and other current assets		756
Property and equipment		246
Other assets		1,202
Warrant assets		448
Goodwill		12,398
Assets acquired, total		34,718
Liabilities assumed
Accounts payable		2,675
Accrued liabilities		4,282
Operating lease obligation		299
Deferred revenue		824
Short-term debt		114
Warrant liability		919
Total liabilities assumed		9,113
Estimated fair value of assets acquired		25,605
Inpixon and Superfly Merger Sub Inc. | Trade Name/Trademarks
Assets acquired
Finite lived assets		913
Inpixon and Superfly Merger Sub Inc. | Proprietary Technology
Assets acquired
Finite lived assets		2,934
Inpixon and Superfly Merger Sub Inc. | Customer Relationships
Assets acquired
Finite lived assets		702
Inpixon and Superfly Merger Sub Inc. | In-Process R&D
Assets acquired
Finite lived assets		$ 243

Proforma Financial Informatio_2

Proforma Financial Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Business Acquisition, Pro Forma Information [Abstract]
Revenues	$ 918	$ 759	$ 2,676	$ 3,486
Net loss attributable to common stockholders	$ (4,674)	$ (9,944)	$ (36,571)	$ (28,397)
Net loss per basic common share (in usd per share)	$ (0.13)	$ (1.17)	$ (1.83)	$ (3.35)
Net loss per diluted common share (in usd per share)	$ (0.13)	$ (1.17)	$ (1.83)	$ (3.35)
Earnings Per Share, Pro Forma [Abstract]
Basic (in shares)	34,986,105	8,476,635	20,006,531	8,475,135
Diluted (in shares)	34,986,105	8,476,635	20,006,531	8,475,135

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Goodwill [Line Items]
Amortization of intangible assets	$ 196	$ 7	$ 431	$ 20
XTI and Inpixon Merger
Goodwill [Line Items]
Goodwill, acquired during period			$ 12,398

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill balance at beginning of period	$ 0
Foreign currency translation adjustment	340
Goodwill balance at end of period	12,738
XTI and Inpixon Merger
Goodwill [Roll Forward]
Goodwill recognized in connection with XTI Merger - Note 5	$ 12,398

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 5,373	$ 421
Accumulated Amortization	(595)	(155)
Net Carrying Amount	4,778	266
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Amount	452	413
Accumulated Amortization	(176)	(155)
Net Carrying Amount	$ 276	258
Remaining Weighted Average Useful Life	9 years 8 months 12 days
Trade Name/Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 945	8
Accumulated Amortization	(103)	0
Net Carrying Amount	$ 842	$ 8
Remaining Weighted Average Useful Life	4 years 6 months
Proprietary Technology
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 3,012
Accumulated Amortization	(237)
Net Carrying Amount	$ 2,775
Remaining Weighted Average Useful Life	6 years 6 months
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 721
Accumulated Amortization	(79)
Net Carrying Amount	$ 642
Remaining Weighted Average Useful Life	4 years 6 months
In-Process R&D
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 243
Accumulated Amortization	0
Net Carrying Amount	$ 243
Remaining Weighted Average Useful Life	3 years

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Intangible Assets Future Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
December 31, 2024 (for 3 months)	$ 198
December 31, 2025	873
December 31, 2026	873
December 31, 2027	873
December 31, 2028	792
December 31, 2029 and thereafter	1,169
Net Carrying Amount	$ 4,778	$ 266

Other Balance Sheet Informati_3

Other Balance Sheet Information - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Inventory [Line Items]
Prepaid insurance	$ 460	$ 13
Other	340	0
Fulfillment costs	286	0
Prepaid software	95	90
Total prepaid expenses and other current assets	1,704	125
Related Party
Inventory [Line Items]
Deposits	523	0
Nonrelated Party
Inventory [Line Items]
Deposits	$ 0	$ 22

Other Balance Sheet Informati_4

Other Balance Sheet Information - Narrative (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Payables and Accruals [Abstract]
Inventory, net	$ 0

Other Balance Sheet Informati_5

Other Balance Sheet Information - Schedule of Inventory (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Payables and Accruals [Abstract]
Raw materials	$ 33
Work-in-process	125
Finished goods	2,572
Total inventory	$ 2,730

Other Balance Sheet Informati_6

Other Balance Sheet Information - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued transaction bonuses	$ 5,782	$ 0
Accrued compensation and benefits	1,120	649
Accrued bonus and commissions	1,196	305
Accrued other	561	173
Total accrued expenses and other current liabilities	$ 8,659	$ 1,127

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Schedule of Short Term and Long Term Debt [Line Items]
Unamortized Discounts	$ (356)	$ (50)
Unamortized Loan Costs	0	(35)
Total Short-Term Debt	2,620	6,690
Unamortized Discounts	0	(1,210)
Total Long-Term Debt	65	18,546
SBA loan | Loans Payable
Schedule of Short Term and Long Term Debt [Line Items]
Long-term debt, gross	65	65
Convertible notes, at fair value | Convertible notes
Schedule of Short Term and Long Term Debt [Line Items]
Long-term debt, gross	0	16,804
Convertible Note 2017 | Convertible notes
Schedule of Short Term and Long Term Debt [Line Items]
Long-term debt, gross	0	1,987
Convertible Note 2022 | Convertible notes
Schedule of Short Term and Long Term Debt [Line Items]
Long-term debt, gross	0	600
Convertible Note 2023 | Convertible notes
Schedule of Short Term and Long Term Debt [Line Items]
Long-term debt, gross	0	300
Notes Payable, Other Payables | Promissory Note - 2023
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross		3,100
Notes Payable, Other Payables | Promissory Note - May 1, 2024
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	1,419	0
Notes Payable, Other Payables | Promissory Note - May 24, 2024
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	1,386	0
Notes Payable, Other Payables | Third Party Note Payable - 2023
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	42	0
Notes Payable, Other Payables | Third Party Note Payable - 2024
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	129	0
Notes Payable, Other Payables | Nonrelated Party | Promissory Note - 2023
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	0	3,071
Notes Payable, Other Payables | Related Party | Promissory Note - 2023
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	0	125
Convertible Notes | Nonrelated Party | Convertible Note 2021
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	0	2,500
Convertible Notes | Related Party | Convertible Note 2021
Schedule of Short Term and Long Term Debt [Line Items]
Short-term debt, gross	$ 0	$ 1,079

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($) $ in Thousands

2 Months Ended

3 Months Ended

9 Months Ended

May 24, 2024

May 01, 2024

Mar. 14, 2024

Mar. 12, 2024

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2024

Sep. 30, 2023

Jun. 30, 2024

Dec. 31, 2023

Oct. 01, 2023

Jan. 05, 2023

Dec. 31, 2021

Jun. 03, 2020

Short-Term Debt [Line Items]

Interest expense, debt

$ 400

$ 300

$ 900

$ 800

Net proceeds from loan from Inpixon (prior to merger)

1,012

$ 0

Interest payable, current

940

940

$ 560

Promissory Note - 2023 | Notes Payable, Other Payables

Short-Term Debt [Line Items]

Short-term debt, gross

3,100

Promissory Note - 2023 | Notes Payable, Other Payables | Related Party

Short-Term Debt [Line Items]

Short-term debt, gross

0

0

125

Promissory Note - 2023 | Notes Payable, Other Payables | Inpixon | XTI

Short-Term Debt [Line Items]

Net proceeds from loan from Inpixon (prior to merger)

$ 1,000

Promissory Note - 2023 | Notes Payable, Other Payables | Board of Directors | Related Party

Short-Term Debt [Line Items]

Debt, initial aggregate principal amount

$ 100

Debt instrument, interest rate, stated percentage

5%

Convertible Note 2021 | Convertible Notes | Related Party

Short-Term Debt [Line Items]

Short-term debt, gross

0

0

1,079

Convertible Note 2021 | Convertible Notes | Syndicate Investors

Short-Term Debt [Line Items]

Debt instrument, interest rate, stated percentage

4%

Convertible notes payable

$ 50

$ 2,500

Interest payable, current

250

250

Convertible Note 2021 | Convertible Notes | Syndicate Investors | XTI

Short-Term Debt [Line Items]

Convertible notes payable

2,500

Convertible Note 2021 | Convertible Notes | Board of Directors | Related Party

Short-Term Debt [Line Items]

Debt instrument, interest rate, stated percentage

4%

Convertible notes payable

$ 900

$ 1,100

Promissory Note - May 1, 2024 | Notes Payable, Other Payables

Short-Term Debt [Line Items]

Short-term debt, gross

1,419

1,419

0

Promissory Note - May 1, 2024 | Notes Payable, Other Payables | Streeterville Capital, LLC

Short-Term Debt [Line Items]

Debt, initial aggregate principal amount

$ 1,400

Debt instrument, interest rate, stated percentage

10%

Debt instrument, term

12 months

Debt instrument, discount

$ 300

First additional promissory note purchase, period from closing date

30 days

Second additional promissory note purchase, period from closing date

60 days

Payment for note purchase agreement

$ 1,000

Debt instrument, stated interest rate

10.50%

Debt instrument, redemption term

6 months

Monthly redemption amount due, period

5 days

Debt instrument redemption price percent

16.70%

Promissory Note - May 24, 2024 | Notes Payable, Other Payables

Short-Term Debt [Line Items]

Short-term debt, gross

1,386

1,386

0

Promissory Note - May 24, 2024 | Notes Payable, Other Payables | Streeterville Capital, LLC

Short-Term Debt [Line Items]

Debt, initial aggregate principal amount

$ 1,300

Debt instrument, discount

300

Payment for note purchase agreement

$ 1,000

Third Party Note Payable - 2023 | Notes Payable, Other Payables

Short-Term Debt [Line Items]

Short-term debt, gross

42

$ 42

0

Debt, initial aggregate principal amount

100

Debt instrument, term

12 months

Debt instrument, interest rate during period

18.60%

Debt instrument, no payments due period

4 months

Debt instrument, payments due, term

8 months

Third Party Note Payable - 2024 | Notes Payable, Other Payables

Short-Term Debt [Line Items]

Short-term debt, gross

129

$ 129

0

Debt, initial aggregate principal amount

$ 400

Debt instrument, interest rate, stated percentage

8.30%

Debt instrument, term

9 months

SBA loan | Loans Payable

Short-Term Debt [Line Items]

Long-term debt, gross

$ 65

$ 65

$ 65

SBA loan | XTI | Loans Payable

Short-Term Debt [Line Items]

Debt instrument, interest rate, stated percentage

3.75%

Common Stock - Narrative (Detai

Common Stock - Narrative (Details) - USD ($)

1 Months Ended

3 Months Ended

5 Months Ended

6 Months Ended

9 Months Ended

Jul. 31, 2024

Jul. 05, 2024

Jun. 14, 2024

Jun. 13, 2024

Jun. 07, 2024

Jun. 06, 2024

Mar. 13, 2024

Mar. 12, 2024

Mar. 11, 2024

Nov. 12, 2024

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Sep. 30, 2023

Jun. 30, 2023

Nov. 12, 2024

Sep. 30, 2024

Sep. 30, 2024

Dec. 31, 2023

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value (in usd per share)

$ 0.001

$ 0.001

$ 0.001

$ 0.001

Common stock issued to Xeriant, Inc. (in shares)

3,142

12,853

Stock issued during period, value, new issues

$ 44,000

$ 180,000

Common shares issued as prepayment for services

$ 335,000

Fully vested restricted stock value

$ 1,101,000

$ 1,192,000

Restricted Stock | Consulting Agreement

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Consulting agreement, cash deposit

$ 100,000

Common shares issued as prepayment for marketing services (in shares)

120,000

309,483

Common shares issued as prepayment for services

$ 100,000

$ 300,000

Share-based compensation arrangement by share-based payment award, award requisite service period

6 months

6 months

Convertible notes, at fair value

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate principal

$ 5,940,000

Common shares issued for extinguishment of debt (in shares)

1,871,000

Net inducement charge

$ 6,732,000

Convertible Note 2021 | Convertible notes, at fair value

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued for extinguishment of debt (in shares)

844,000

Net inducement charge

$ 3,266,000

Convertible Note 2021 | Related Party | Convertible notes, at fair value

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Long-term debt

$ 200,000

Inpixon | Convertible Note 2021 | Convertible notes, at fair value

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate principal

$ 2,504,000

Convertible debt, conversion price (in usd per share)

$ 0.265

Common Stock | Convertible notes, at fair value

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate principal

$ 5,552,000

Common Stock | Inpixon | Convertible Note 2021 | Convertible notes, at fair value

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate principal

2,777,000

Streeterville Capital, LLC

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock issued during period, value, conversion of convertible securities

$ 4,856,250

Streeterville Capital, LLC | Common Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued for conversion of preferred shares (in shares)

7,196,000

Stock issued during period, value, conversion of convertible securities

$ 12,900,000

XTI | Inpixon | Convertible Note 2021 | Related Party

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate principal

$ 900,000

Convertible debt, conversion price (in usd per share)

$ 0.309

Common shares issued for extinguishment of debt (in shares)

266,272

Net inducement charge

$ 1,000,000

Mr. Nadir Ali | CEO and Director | Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued as prepayment for marketing services (in shares)

1,000,000

Common shares issued as prepayment for services

$ 300,000

Mr. Nadir Ali | CEO and Director | Restricted Stock | Consulting Agreement | 2018 Employee Stock Incentive Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued as settlement of accrued compensation (in shares)

2,774,883

2,680,459

Fully vested restricted stock value

$ 1,100,000

$ 1,200,000

Common Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Aggregate principal

$ 16,800,000

Common shares issued for conversion of preferred shares (in shares)

751,226

Common shares issued (in shares)

2,075,743

Common shares issued as prepayment for marketing services (in shares)

429,483

Common shares issued as settlement of accrued compensation (in shares)

2,774,883

2,680,459

Fully vested restricted stock value

$ 3,000

$ 3,000

Common Stock | Inpixon

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued (in shares)

2,075,743

Common Stock | Xeriant, Inc

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock issued to Xeriant, Inc. (in shares)

298,395

Subsequent Event | Common Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common shares issued for conversion of preferred shares (in shares)

25,071,318

Equity Distribution Agreement

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Sale of common stock, authorized, amount

$ 83,800,000

$ 48,800,000

Common stock, par value (in usd per share)

$ 0.001

Fixed commission rate

3%

Common stock issued to Xeriant, Inc. (in shares)

3,190,727

12,490,930

Sale of stock, consideration received on transaction

$ 1,000,000

$ 9,600,000

Sale of common stock, maximum amount

$ 47,400,000

Stock issued during period, value, new issues

6,000,000

Sale of common stock, after the initial tranche up to the ATM maximum amount

$ 5,000,000

Equity Distribution Agreement | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock issued to Xeriant, Inc. (in shares)

101,704,300

Sale of stock, consideration received on transaction

$ 45,200,000

Share repurchase, remaining authorized amount

$ 38,600,000

$ 38,600,000

Equity Distribution Agreement | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Price per share during period (in usd per share)

$ 0.19

$ 0.19

Equity Distribution Agreement | Minimum | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share price (in usd per share)

$ 0.06

$ 0.06

Equity Distribution Agreement | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Price per share during period (in usd per share)

$ 0.43

$ 1.35

Equity Distribution Agreement | Maximum | Subsequent Event

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share price (in usd per share)

$ 1.86

$ 1.86

Common Stock - Schedule of Debt

Common Stock - Schedule of Debt Conversions (Details) - Convertible notes - USD ($)	Mar. 12, 2024	Mar. 11, 2024
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 5,940,000
Exchange Ratio Common Shares (in shares)	1,871,000
Net Inducement Charge	$ 6,732,000
XTI
Debt Conversion [Line Items]
Outstanding Payment Obligation Immediately After XTI Merger	$ 388,000
Common Stock
Debt Conversion [Line Items]
Aggregate Principal and Interest		5,552,000
Convertible Note 2021
Debt Conversion [Line Items]
Exchange Ratio Common Shares (in shares)	844,000
Net Inducement Charge	$ 3,266,000
Convertible Note 2021 | XTI
Debt Conversion [Line Items]
Outstanding Payment Obligation Immediately After XTI Merger	$ 273,000
Convertible Note 2021 | Inpixon
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 2,504,000
Reduced Conversion Price (in dollars per share)		$ 0.265
Convertible Note 2021 | Inpixon | Common Stock
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 2,777,000
Convertible Note 2017
Debt Conversion [Line Items]
Exchange Ratio Common Shares (in shares)	724,000
Net Inducement Charge	$ 2,795,000
Convertible Note 2017 | XTI
Debt Conversion [Line Items]
Outstanding Payment Obligation Immediately After XTI Merger	$ 0
Convertible Note 2017 | Inpixon
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 2,148,000
Reduced Conversion Price (in dollars per share)		$ 0.265
Convertible Note 2017 | Inpixon | Common Stock
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 2,148,000
Convertible Note 2022
Debt Conversion [Line Items]
Exchange Ratio Common Shares (in shares)	202,000
Net Inducement Charge	$ 464,000
Convertible Note 2022 | XTI
Debt Conversion [Line Items]
Outstanding Payment Obligation Immediately After XTI Merger	$ 82,000
Convertible Note 2022 | Inpixon
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 600,000
Reduced Conversion Price (in dollars per share)		$ 0.265
Convertible Note 2022 | Inpixon | Common Stock
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 682,000
Convertible Note 2023
Debt Conversion [Line Items]
Exchange Ratio Common Shares (in shares)	101,000
Net Inducement Charge	$ 207,000
Convertible Note 2023 | XTI
Debt Conversion [Line Items]
Outstanding Payment Obligation Immediately After XTI Merger	$ 33,000
Convertible Note 2023 | Inpixon
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 300,000
Reduced Conversion Price (in dollars per share)		$ 0.265
Convertible Note 2023 | Inpixon | Common Stock
Debt Conversion [Line Items]
Aggregate Principal and Interest		$ 333,000

Preferred Stock - Narrative (De

Preferred Stock - Narrative (Details)				3 Months Ended			6 Months Ended	9 Months Ended
	Apr. 30, 2024 d	Mar. 13, 2024 USD ($)	Mar. 12, 2024 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 $ / shares shares
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares) | shares				5,000,000			5,000,000	5,000,000	5,000,000
Preferred stock, par value (in usd per share) | $ / shares				$ 0.001			$ 0.001	$ 0.001	$ 0.001
Preferred stock, annual rate of return			10%
Dividends in excess of retained earnings | $				$ 185,000	$ 250,000	$ 61,000
Streeterville Capital, LLC
Class of Stock [Line Items]
Stock issued during period, value, conversion of convertible securities | $							$ 4,856,250
Streeterville Capital, LLC | December 2023 Note | Convertible Notes
Class of Stock [Line Items]
Aggregate amount | $			$ 9,800,000
Series 9 Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares) | shares				20,000			20,000	20,000	20,000
Preferred stock, par value (in usd per share) | $ / shares			$ 0.001
Preferred stock, shares issued (in shares) | shares			20,000	11,302			11,302	11,302	0
Preferred stock, stated face value (in usd per share) | $ / shares			$ 1,050
Preferred stock, initial dividend rate term			1 year
Preferred stock, subsequent dividend rate term			2 years
Corporation optional conversion period | d	5
Stock issued during period, value, conversion of convertible securities | $				$ 54,000	$ 177,000
Series 9 Preferred Stock | Private Placement
Class of Stock [Line Items]
Number of shares sold under offering (in shares) | shares			1,500
Sale of stock, consideration received on transaction | $			$ 1,500,000
Share price (in usd per share) | $ / shares			$ 1,000
Series 9 Preferred Stock | Dividend Issuance Period One
Class of Stock [Line Items]
Preferred stock, quarterly dividend rate			2%
Series 9 Preferred Stock | Dividend Issuance Period Two
Class of Stock [Line Items]
Preferred stock, quarterly dividend rate			3%
Series 9 Preferred Stock | Streeterville Capital, LLC | December 2023 Note | Convertible Notes
Class of Stock [Line Items]
Common shares issued for extinguishment of debt (in shares) | shares			9,802
Convertible debt, conversion price (in usd per share) | $ / shares			$ 1,000
Series 9 Preferred Stock at Redemption Value | Streeterville Capital, LLC
Class of Stock [Line Items]
Common shares issued for conversion of preferred shares (in shares) | shares							4,625
Series 9 Preferred Stock at Redemption Value | Streeterville Capital, LLC | Minimum
Class of Stock [Line Items]
Preferred stock, convertible, conversion price (in usd per share) | $ / shares				$ 0.2085			$ 0.2085	$ 0.2085
Series 9 Preferred Stock at Redemption Value | Streeterville Capital, LLC | Maximum
Class of Stock [Line Items]
Preferred stock, convertible, conversion price (in usd per share) | $ / shares				$ 2.96			$ 2.96	$ 2.96
Common Stock | Streeterville Capital, LLC
Class of Stock [Line Items]
Common shares issued for conversion of preferred shares (in shares) | shares							7,196,000
Stock issued during period, value, conversion of convertible securities | $		$ 12,900,000
Dividends in excess of retained earnings | $				$ 53,750				$ 230,730

Stock Award Plans and Stock-B_2

Stock Award Plans and Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands					3 Months Ended		6 Months Ended	9 Months Ended
	Aug. 01, 2024 $ / shares	Jun. 12, 2024 $ / shares	Mar. 12, 2024 shares	Mar. 11, 2024 shares	Sep. 30, 2023 shares	Jun. 30, 2023 shares	Jun. 30, 2024 USD ($)	Sep. 30, 2024 USD ($) incentive_plan shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of incentive plans | incentive_plan								3
Exercise price limit (percent)								100%
Exercise price limit for individuals owning over ten percent (percent)								110%
Unrecognized compensation expense related to unvested awards | $								$ 6,400
Weighted average remaining term								1 year 11 months 8 days
Common stock issued to Xeriant, Inc. (in shares)					3,142	12,853
Non-Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $								$ 240
Non-Executive Officer | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued to Xeriant, Inc. (in shares)			46,265
Scott Pomeroy | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $								1,900
Scott Pomeroy | Chief Executive Officer | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, shares issued (in shares)			357,039
Maxim Group LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $							$ 2,030
Maxim Group LLC | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued to Xeriant, Inc. (in shares)			385,359
Chardan Capital Markets
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $								$ 1,000
Chardan Capital Markets | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued to Xeriant, Inc. (in shares)			189,036
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, expiration period								10 years
Vesting period								4 years
Two Thousand Seventeen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, expiration period								10 years
Shares available for future grant (in shares)								0
Share-based payment arrangement, option inducement, net exercised into common shares (in shares)			92,728
Two Thousand Seventeen Plan | Inpixon
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, option inducement, net exercised into common shares (in shares)				1,038,871
Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future grant (in shares)								0
Vesting period	3 years	3 years
2018 Plan aggregate number of options authorized (in shares)								67,148,179
Aggregate number of shares available for future grant under stock option plan (in shares)								52,370,064
Stock option exercise price (in usd per share) | $ / shares	$ 0.473	$ 0.473
Two Thousand Eighteen Plan | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		33.30%
Two Thousand Eighteen Plan | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		33.30%
Two Thousand Eighteen Plan | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		33.30%

Stock Award Plans and Stock B_2

Stock Award Plans and Stock Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Number of Shares
Beginning balance (in shares)	1,161,687
Legacy Inpixon stock options from merger (in shares)	1,148
Granted (in shares)	12,565,606
Exercised (in shares)	(92,718)
Expired (in shares)	(242)
Forfeitures (in shares)	(853,299)
Ending balance (in shares)	12,782,182	1,161,687
Weighted Average Exercise Price
Beginning balance (in usd per share)	$ 17.95
Legacy Inpixon stock options from merger (in usd per shares)	61.67
Granted (in usd per share)	0.47
Exercised (in usd per share)	0
Expired (in usd per share)	19,043.35
Forfeitures (in usd per share)	8.83
Ending balance (in usd per share)	$ 1.87	$ 17.95
Stock Options Additional Disclosures
Beginning balance, weighted average remaining contractual life	9 years 7 months 6 days	6 years 8 months 12 days
Ending balance, weighted average remaining contractual life	9 years 7 months 6 days	6 years 8 months 12 days
Beginning balance, Aggregate intrinsic value	$ 0
Ending balance, Aggregate intrinsic value	$ 0	$ 0
Options vested and exercisable (in shares)	852,174
Options vested and exercisable (in usd per shares)	$ 15.13
Options vested and exercisable, weighted average remaining contractual life	7 years 7 months 6 days
Options vested and exercisable, Aggregate intrinsic value	$ 0

Stock Award Plans and Stock B_3

Stock Award Plans and Stock Based Compensation - Schedule of Stock Options Granted (Details) - shares		9 Months Ended
	Jun. 12, 2024	Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		12,565,606
Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	6,600,000
Chief Executive Officer | Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	2,812,500
Chief Financial Officer | Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	1,640,625
Chief Executive Officer (Real-Time Location System Division) | Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	975,000
Chief Strategy Officer | Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	1,171,875

Stock Award Plans and Stock B_4

Stock Award Plans and Stock Based Compensation - Schedule of Estimating the Fair Values of Options (Details) - Two Thousand Eighteen Plan	9 Months Ended
	Sep. 30, 2024 $ / shares
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in usd per share)	$ 0.191
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in usd per share)	$ 0.473
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	10 years
Volatility, minimum	95.06%
Volatility, maximum	96.17%
Risk-free interest rate, minimum	3.58%
Risk-free interest rate, maximum	4.32%
Dividend yield	0%
Options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, share price (in usd per share)	$ 0.191
Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, share price (in usd per share)	$ 0.473

Stock Award Plans and Stock B_5

Stock Award Plans and Stock Based Compensation - Schedule of Stock-based Compensation Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Professional fees	$ 270	$ 0	$ 270	$ 0
Merger-related professional fees	0	0	5,153	0
Total	(1,889)	164	3,844	2,766
Employee And Consultant Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges	(2,159)	164	(2,075)	2,766
Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges	$ 0	$ 0	$ 496	$ 0

Warrants - Schedule of Stockhol

Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	9 Months Ended
	Sep. 30, 2024 shares
Number of Warrants
Beginning balance (in shares)	1,161,687
Legacy Inpixon stock options from merger (in shares)	1,148
Granted (in shares)	12,565,606
Exercised (in shares)	(92,718)
Expired (in shares)	(242)
Exchanged (in shares)	(853,299)
Ending balance (in shares)	12,782,182
Warrants
Number of Warrants
Beginning balance (in shares)	771,895
Legacy Inpixon stock options from merger (in shares)	1,448,481
Granted (in shares)	167,664
Exercised (in shares)	(409,815)
Expired (in shares)	(96,659)
Exchanged (in shares)	(1,602,630)
Ending balance (in shares)	278,936
Exercisable (in shares)	89,780

Warrants - Narrative (Details)

Warrants - Narrative (Details) - USD ($)							3 Months Ended			9 Months Ended
	Jun. 13, 2024	Jun. 12, 2024	May 30, 2024	May 02, 2024	Mar. 12, 2024	Mar. 11, 2024	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 21, 2024	Dec. 31, 2023	Dec. 19, 2023	Dec. 15, 2023	May 17, 2023
Class of Warrant or Right [Line Items]
Exercise price of warrants (in usd per share)							$ 0.01		$ 0.01	$ 0.01	$ 0.01
Stock-based compensation										$ 3,844,000	$ 2,766,000
Issuance of common stock for exercise of options (in shares)										92,718
Number of securities called by warrants or rights (in shares)			112,360
Common shares issued in exchange of warrants			$ 106,742					$ 1,981,000
Fair value adjustment of warrants							$ 0		$ 0	$ (281,000)	$ (126,000)
Granted (in shares)										12,565,606
Warrant liability							$ 0			$ 0			$ 497,000
Common Stock
Class of Warrant or Right [Line Items]
Stock issued during period, warrant exchange (in shares)								1,492,415
Common shares issued in exchange of warrants								$ 2,000
Warrant Inducement Agreement
Class of Warrant or Right [Line Items]
Exercise price of warrants (in usd per share)												$ 5.13			$ 7.324
Issuance of common stock for exercise of options (in shares)					1,182,522
Warrant Inducement Agreement | XTI | Post Merger Exchange Common Shares
Class of Warrant or Right [Line Items]
Issuance of common stock for exercise of options (in shares)										105,550
March 2024 Warrant Amendment | XTI Aircraft Company | Share-based Payment Arrangement, Tranche One
Class of Warrant or Right [Line Items]
Award vesting rights, percentage						33.30%
March 2024 Warrant Amendment | XTI Aircraft Company | Share-based Payment Arrangement, Tranche Two
Class of Warrant or Right [Line Items]
Award vesting rights, percentage						16.70%
March 2024 Warrant Amendment | XTI Aircraft Company | Share-based Payment Arrangement, Tranche Three
Class of Warrant or Right [Line Items]
Award vesting rights, percentage						16.70%
March 2024 Warrant Amendment | XTI Aircraft Company | Share-based Payment Arrangement, Tranche Four
Class of Warrant or Right [Line Items]
Award vesting rights, percentage						33.30%
March 2024 Warrant Amendment | XTI
Class of Warrant or Right [Line Items]
Stock-based compensation										$ 500,000
Share-based compensation arrangement by share-based payment award, options, vested, number of shares (in shares)										189,156
March 2024 Warrant Amendment | XTI | Post Merger Exchange Common Shares
Class of Warrant or Right [Line Items]
Issuance of common stock for exercise of options (in shares)					283,737
Additional Warrant Exercises Issued by Legacy XTI | XTI
Class of Warrant or Right [Line Items]
Issuance of common stock for exercise of options (in shares)								20,528
Additional Warrant Exercises Issued by Legacy XTI | Common Stock | XTI
Class of Warrant or Right [Line Items]
Exercise price of warrants (in usd per share)								$ 0.12
Number of securities called by warrants or rights (in shares)								20,528
Existing Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in usd per share)	$ 1.50			$ 0.70
Number of securities called by warrants or rights (in shares)	491,314	491,314												491,314		918,690
Stock issued during period, warrant exchange (in shares)	736,973			643,082
Common shares issued in exchange of warrants				$ 1,590,859
Fair value adjustment of warrants				$ 672,174
Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in usd per share)	$ 0.44	$ 0.47
Stock issued during period, warrant exchange (in shares)	73,392	663,581
Common shares issued in exchange of warrants										$ 344,176
Warrant liability		$ 61,000
Fair value assumptions, expected dividend rate	0%	0%
Fair value assumptions, risk free interest rate	4.30%	4.40%
Fair value assumptions, share price (in usd per share)	$ 0.44	$ 0.47
Exercise price (in usd per share)	$ 5.13	$ 5.13
Fair value assumptions, expected term	4 years 6 months 3 days	4 years 6 months 3 days
Fair value assumptions, expected volatility rate	91%	90%
Increase in fair value of warrants, reduction to additional paid in capital										$ 283,176
Assumed Warrants
Class of Warrant or Right [Line Items]
Number of securities called by warrants or rights (in shares)			192,626
Fair value adjustment of warrants			$ 6,742

Segments - Narrative (Details)

Segments - Narrative (Details)	9 Months Ended
	Sep. 30, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segments - Schedule of Revenue

Segments - Schedule of Revenue by Major Customers and Reporting Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue, Major Customer [Line Items]
Total segment revenue	$ 918	$ 0	$ 2,169	$ 0
Gross profit by Segment	520	0	1,323	0
Research and Development Expenses by Segment	1,228	472	2,840	1,299
Consolidated loss from operations	(4,216)	(2,378)	(27,020)	(7,702)
Segment
Revenue, Major Customer [Line Items]
Total segment revenue	918	0	2,169	0
Gross profit by Segment	520	0	1,323	0
Research and Development Expenses by Segment	1,228	472	2,840	1,299
Consolidated loss from operations	476	(2,378)	(9,949)	(7,702)
Segment Reconciling Items
Revenue, Major Customer [Line Items]
Consolidated loss from operations	(4,692)	0	(17,071)	0
Industrial IoT | Segment
Revenue, Major Customer [Line Items]
Total segment revenue	918	0	2,169	0
Gross profit by Segment	520	0	1,323	0
Research and Development Expenses by Segment	609	0	1,361	0
Consolidated loss from operations	(1,312)	0	(2,788)	0
Commercial Aviation | Segment
Revenue, Major Customer [Line Items]
Total segment revenue	0	0	0	0
Gross profit by Segment	0	0	0	0
Research and Development Expenses by Segment	619	472	1,479	1,299
Consolidated loss from operations	$ 1,788	$ (2,378)	$ (7,161)	$ (7,702)

Segments - Schedule of Total As

Segments - Schedule of Total Assets by Reportable Segment (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Assets	$ 29,283	$ 509
Segment
Segment Reporting Information [Line Items]
Assets	22,814	509
Segment | Industrial IoT
Segment Reporting Information [Line Items]
Assets	21,583	0
Segment | Commercial Aviation
Segment Reporting Information [Line Items]
Assets	1,231	509
Corporate, Non-Segment
Segment Reporting Information [Line Items]
Assets	$ 6,469	$ 0

Fair Value Measures and Disclos

Fair Value Measures and Disclosures - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Oct. 26, 2023	Sep. 30, 2024	May 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of securities called by warrants or rights (in shares)			112,360
Exercise price of warrants (in usd per share)		$ 0.01			$ 0.01
Convertible note and warrant asset		$ 4,000
Note receivable available for sale, at fair value		3,601		$ 0
Warrant asset		$ 424		$ 0
Inpixon | Bridge Note | Damon Motors Inc.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Class of warrant or right, term	5 years
Number of securities called by warrants or rights (in shares)	1,096,321
Exercise price of warrants (in usd per share)	$ 2.7364
Class of warrant or right, cashless exercise option, period	180 days
Convertible Notes Receivable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Financing receivable, stated interest rate	12%
Financing receivable, aggregate principal amount	$ 3,000
Purchase of notes receivable	$ 3,000

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of Fair Value of Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Assets:
Notes receivable	$ 3,601
Warrant asset	424
Total assets	4,025
Liabilities:
Warrant liability		$ 497
Convertible notes, at fair value		16,804
Loan conversion derivatives		333
Total liabilities		17,634
Level 1
Assets:
Notes receivable	0
Warrant asset	0
Total assets	0
Liabilities:
Warrant liability		0
Convertible notes, at fair value		0
Loan conversion derivatives		0
Total liabilities		0
Level 2
Assets:
Notes receivable	0
Warrant asset	0
Total assets	0
Liabilities:
Warrant liability		0
Convertible notes, at fair value		0
Loan conversion derivatives		0
Total liabilities		0
Level 3
Assets:
Notes receivable	3,601
Warrant asset	424
Total assets	$ 4,025
Liabilities:
Warrant liability		497
Convertible notes, at fair value		16,804
Loan conversion derivatives		333
Total liabilities		$ 17,634

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Schedule of Reconciliation of Liabilities for Level 3 Investments (Details) - Level 3 - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024
Notes Receivable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning balance	$ 3,442	$ 3,264	$ 0
Acquired			3,264
Change in fair value	20	38	0
Accrued interest	90	91
Debt discount recognition	49	49
Exchanged / Conversion to Equity		0	0
Ending balance	3,601	3,442	3,264
Warrant Asset
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning balance	424	448	0
Acquired			448
Change in fair value	0	(24)	0
Accrued interest	0	0
Debt discount recognition	0	0
Exchanged / Conversion to Equity		0	0
Ending balance	424	424	448
Warrant liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning balance	0	1,019	497
Acquired			920
Change in fair value	0	679	(398)
Accrued interest	0	0
Debt discount recognition	0	0
Exchanged / Conversion to Equity		(1,698)	0
Ending balance	0	0	1,019
Convertible notes, at fair value
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning balance	0	0	16,804
Acquired			0
Change in fair value	0	0	(12,882)
Accrued interest	0	0
Debt discount recognition	0	0
Exchanged / Conversion to Equity		0	(3,922)
Ending balance	0	0	0
Loan conversion derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning balance	0	0	333
Acquired			0
Change in fair value	0	0	0
Accrued interest	0	0
Debt discount recognition	0	0
Exchanged / Conversion to Equity		0	(333)
Ending balance	$ 0	$ 0	$ 0

Foreign Operations (Details)

Foreign Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues by geographic area	$ 918	$ 0	$ 2,169	$ 0
Operating (loss) income by geographic area	(4,216)	(2,378)	(27,020)	(7,702)
Net (loss) income by geographic area	(4,435)	(2,703)	(21,747)	(8,897)
Identifiable assets by geographic area	29,283		29,283		$ 509
Long lived assets by geographic area	5,535		5,535		278
Goodwill by geographic area	12,738		12,738		0
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues by geographic area	(139)	0	(278)	0
Operating (loss) income by geographic area	0	0	0	0
Net (loss) income by geographic area	0	0	0	0
Identifiable assets by geographic area	(37,302)		(37,302)		0
Long lived assets by geographic area	0		0		0
Goodwill by geographic area	0		0		0
United States | Reportable Geographical Components
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues by geographic area	435	0	758
Operating (loss) income by geographic area	(3,167)	(2,378)	(25,146)	(7,702)
Net (loss) income by geographic area	(3,389)	(2,703)	(19,886)	(8,897)
Identifiable assets by geographic area	43,253		43,253		509
Long lived assets by geographic area	2,086		2,086		278
Goodwill by geographic area	3,142		3,142		0
Germany | Reportable Geographical Components
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues by geographic area	622	0	1,689	0
Operating (loss) income by geographic area	(1,049)	0	(1,874)	0
Net (loss) income by geographic area	(1,046)	0	(1,861)	0
Identifiable assets by geographic area	23,322		23,322		0
Long lived assets by geographic area	3,449		3,449		0
Goodwill by geographic area	9,596		9,596		0
United Kingdom | Reportable Geographical Components
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues by geographic area	0	0	0	0
Operating (loss) income by geographic area	0	0	0	0
Net (loss) income by geographic area	0	$ 0	0	$ 0
Identifiable assets by geographic area	10		10		0
Long lived assets by geographic area	0		0		0
Goodwill by geographic area	$ 0		$ 0		$ 0

Related Party Transactions (Det

Related Party Transactions (Details) $ in Thousands			3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 12, 2024 USD ($) installment	Feb. 21, 2024 USD ($) installment	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)	Nov. 14, 2024	Dec. 31, 2023 USD ($)
Related Party Transaction [Line Items]
Accrued transaction bonuses			$ 5,782		$ 5,782		$ 0
AVX Aircraft
Related Party Transaction [Line Items]
Related party transaction amount			800		900
Related party transaction, amounts for future services			500		500
AVX Aircraft | Subsequent Event
Related Party Transaction [Line Items]
Percent of shares owned by related party						26%
Ali Consulting Agreement
Related Party Transaction [Line Items]
Related party transaction amount	$ 1,500
Related party transaction. consulting service minimum period	15 months
Related party transaction. consulting service monthly fee	$ 300
Number of installments | installment	12
Related party transaction, monthly terms	4 months
Accrued consulting fees	$ 1,000
Accrued transaction bonuses			2,700	$ 6,700	2,700
Related Party
Related Party Transaction [Line Items]
Payable			100		100		540
Related Party | Ali Consulting Agreement
Related Party Transaction [Line Items]
Payable	$ 4,500
Share-based payment charges			1,000		2,600
David Brody | Related Party
Related Party Transaction [Line Items]
Payable							300
Scott Pomeroy | Related Party
Related Party Transaction [Line Items]
Payable			$ 100		100		$ 100
Grafiti LLC, and Grafiti Group LLC | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Saves, Shoom and Game Your Game Business Lines
Related Party Transaction [Line Items]
Disposal group, including discontinued operation, percentage of equity interest sold		100%
Disposal group, including discontinued operation, percentage of equity interests sold of foreign subsidiary		100%
Disposal group, including discontinued operation, consideration		$ 1,000
Disposal group, including discontinued operation, number of annual cash installments | installment		2
Disposal group, including discontinued operation, expected price of acquisition, cash installment amount		$ 500		$ 500	$ 500
Disposal group, including discontinued operation, initial cash installment, period due		60 days
Disposal group, including discontinued operation, future cash installment, percentage increase of net income, net of tax		50%
Disposal group, including discontinued operation, future cash installment, working capital variance to closing balance sheet amount		$ 1,000

Commitments and Contingencies (

Commitments and Contingencies (Details)					3 Months Ended	9 Months Ended
	Aug. 01, 2024 USD ($)	Mar. 12, 2024 USD ($)	Feb. 29, 2024 USD ($)	Dec. 06, 2023 unnamed_person unnamed_company	Sep. 30, 2024 USD ($)	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Apr. 03, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)
Loss Contingencies [Line Items]
Accrued transaction bonuses					$ 5,782,000	$ 5,782,000			$ 0
Ali Consulting Agreement
Loss Contingencies [Line Items]
Related party transaction. consulting service monthly fee		$ 300,000
Accrued consulting fees		1,000,000
Percentage of accrued transaction bonus expense							100%
Accrued transaction bonuses					2,700,000	2,700,000	$ 6,700,000
Aggregate accrued transaction bonus					5,500,000	5,500,000
Chief Financial Officer | Loundermon Consulting Agreement
Loss Contingencies [Line Items]
Related party transaction. consulting service monthly fee		$ 83,333
Related party transaction, compensation of consulting service monthly , terms and manner of settlement		6 months
Related party transaction, consulting service fee per hour		$ 300
Share-based payment charges					211,063	577,880
Accrued consulting fees					522,619	522,619
Related Party | Ali Consulting Agreement
Loss Contingencies [Line Items]
Share-based payment charges					1,000,000	2,600,000
Accrued Liabilities
Loss Contingencies [Line Items]
Loss contingency accrual					400,000	400,000
Accrued Liabilities | Related Party
Loss Contingencies [Line Items]
Loss contingency accrual					100,000	100,000
Auctus Fund, LLC
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss								$ 8,435,008.81
Auctus Fund, LLC | Senior Secured Promissory Note | Xeriant, Inc
Loss Contingencies [Line Items]
Debt, initial aggregate principal amount										$ 6,050,000
Maxim | Inpixon and Superfly Merger Sub Inc.
Loss Contingencies [Line Items]
Financial advisory fees, amounts payable					200,000	200,000
Financial advisory fees, amount payable, minimum aggregate proceeds raised					10,000,000	10,000,000
Xeriant, Inc. Against XTI Aircraft Company
Loss Contingencies [Line Items]
Loss contingency, number of unnamed companies | unnamed_company				2
Loss contingency, number of unnamed persons | unnamed_person				5
Loss contingency, damages sought			$ 500,000,000
Chardan Capital Markets LLC Against XTI Aircraft Company | Pending Litigation | Engagement Letter Agreement, Payment One
Loss Contingencies [Line Items]
Loss contingency, damages sought	$ 200,000
Loss contingency accrual					$ 200,000	$ 200,000
Chardan Capital Markets LLC Against XTI Aircraft Company | Pending Litigation | Engagement Letter Agreement, Payment Two
Loss Contingencies [Line Items]
Loss contingency, damages sought	94,511
Chardan Capital Markets LLC Against XTI Aircraft Company | Pending Litigation | Engagement Letter Agreement, Payment Three
Loss Contingencies [Line Items]
Loss contingency, damages sought	484,044
Chardan Capital Markets LLC Against XTI Aircraft Company | Pending Litigation | Engagement Letter Agreement, Payment Four
Loss Contingencies [Line Items]
Loss contingency, damages sought	$ 174,000

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Net Loss	$ (4,435)	$ (14,710)	$ (2,602)	$ (2,703)	$ (4,629)	$ (1,565)	$ (21,747)	$ (8,897)
Less: Preferred stock return and dividend	(185)			0			(496)	0
Less: Deemed dividend	(54)			0			(514)	0
Net Loss Attributable to Common Stockholders, basic	(4,674)			(2,703)			(22,757)	(8,897)
Net Loss Attributable to Common Stockholders, diluted	$ (4,674)			$ (2,703)			$ (22,757)	$ (8,897)
Net Loss Per Share
Net Loss Per Share - Basic (in usd per share)	$ (0.13)			$ (0.66)			$ (1.23)	$ (2.26)
Net Loss Per Share - Diluted (in usd per share)	$ (0.13)			$ (0.66)			$ (1.23)	$ (2.26)
Weighted Average Number of Shares Outstanding
Diluted (in shares)	34,986,105			4,116,700			18,439,744	3,931,075
Basic (in shares)	34,986,105			4,116,700			18,439,744	3,931,075

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	13,097,495	2,005,119	6,594,133	1,887,498
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	12,818,530	1,161,688	5,791,342	1,095,195
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	278,963	163,603	457,094	142,276
Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	2	0	2	0
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	0	679,828	345,695	650,027

Net Loss Per Share Attributab_5

Net Loss Per Share Attributable to Common Stockholders - Narrative (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Weighted average number of shares, penny warrant shares (in shares)	209,688	608,528	608,528	608,528
Exercise price of warrants (in usd per share)	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Weighted average number of shares, issuable to joint venture arrangement (in shares)	298,395	298,395	298,395

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event $ / shares in Units, $ in Millions	1 Months Ended
	Nov. 12, 2024 USD ($) $ / shares shares
Series 9 Preferred Stock
Subsequent Event [Line Items]
Conversion of stock, shares converted (in shares) | shares	1,725
Conversion of stock, amount converted | $	$ 1.8
Series 9 Preferred Stock | Minimum
Subsequent Event [Line Items]
Preferred stock, convertible, conversion price (in usd per share)	$ 0.05
Series 9 Preferred Stock | Maximum
Subsequent Event [Line Items]
Preferred stock, convertible, conversion price (in usd per share)	$ 0.19
Common Stock
Subsequent Event [Line Items]
Common shares issued for conversion of preferred shares (in shares) | shares	25,071,318
Common Stock | ATM
Subsequent Event [Line Items]
Number of shares sold under offering (in shares) | shares	88,509,614
Sale of stock, aggregate net proceeds | $	$ 6.5
Common Stock | Minimum | ATM
Subsequent Event [Line Items]
Share price (in usd per share)	$ 0.06
Common Stock | Maximum | ATM
Subsequent Event [Line Items]
Share price (in usd per share)	$ 0.19